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ABSTRACT 
 
KATHERINE MAURINE HORVATH: Cigarette Smoke Alters Influenza Induced Immune 
Responses of the Respiratory Epithelium 
(Under the direction of Ilona Jaspers) 
 
Epidemiological evidence demonstrates that smokers are at increased risk for and 
suffer greater morbidity and mortality from influenza infection but the mechanism 
underlying this susceptibility is poorly understood. Previous work from our laboratory 
confirmed that smokers have increased markers of influenza infection using both in vivo and 
in vitro models of influenza infection. In this dissertation, the differential nasal immune 
responses to influenza infection were explored in nonsmokers and smokers. In the in vitro 
model of influenza infection, nasal epithelial cells (NEC) obtained from nonsmokers and 
smokers were differentiated ex vivo and co-cultured with monocyte-derived dendritic cells 
(mono-DCs) from nonsmokers to determine the effect of cigarette smoke (CS) exposure on 
the ability of NEC to communicate with underlying DCs. These co-cultures were then 
infected with influenza A virus. Both NEC from smokers and mono-DCs co-cultured with 
smoker NEC had decreased expression of antiviral mediators interferon regulatory factor 7 
(IRF7) and Th1 cell chemokine interferon gamma-induced protein 10 kDa (IP-10) with 
increased expression of Th2 chemokine thymic stromal lymphopoeitin (TSLP). Thus, CS 
exposure altered antiviral defense mechanisms in both NEC and mono-DCs and changed the 
nature of communication between these two cell types. In the in vivo model of human 
iv 
influenza infection, nonsmokers and smokers were administered live attenuated influenza 
virus (LAIV) and the resulting localized nasal immune responses were monitored using nasal 
lavages and nasal biopsies. Natural killer (NK) cell cytotoxic responses and chemokines 
important for NK cell activation were suppressed in smoker nasal lavages. This data was 
intriguing because 1) it was the first documentation of NK cells in the nasal lavage cell 
population and 2) decreased NK cell activity in smokers could contribute to delayed 
influenza virus clearance. These data were also the first to show that γδ T intraepithelial 
lymphocytes, a rare immune cell type, migrated to the nasal mucosa following LAIV 
inoculation in both nonsmokers and smokers. Together these data demonstrate that CS 
exposure suppresses NK, NEC, and DC specific immune responses of the respiratory mucosa 
and contribute to the mechanism of increased susceptibility to respiratory viruses observed in 
CS exposed populations.  
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CHAPTER 1 
INTRODUCTION 
Host Defense at the Respiratory Mucosa   
The respiratory epithelium functions as a barrier against the outside world and is 
the first line of defense against airborne environmental stimuli, including pollutants, 
pathogens, and allergens. Respiratory epithelial cells form a ciliated, polarized, and 
pseudostratified columnar epithelium. The apical side of the cell is exposed to the outside 
environment whereas the basolateral side of the cell communicates with underlying 
lamina propria and, in the case of a pathogenic infection or pollutant exposure, can 
secrete mediators to attract immune cells to airways under assault (see Figure 1). 
Respiratory epithelial and immune cells participate in complex crosstalk to orchestrate 
innate and adaptive inflammatory responses in the respiratory epithelium. Innate host 
defense is characterized by non-specific immune cells including neutrophils, 
macrophages, and dendritic cells (DCs) that recognize general pathogens and 
environmental stimuli and direct the initial stages of immune responses. Innate immune 
responses transition into adaptive immune mechanisms that generate pathogen specific T 
and B lymphocytes to eliminate the invading pathogen at its source, destroy infected 
and/or damaged host tissue, and regulate both innate and adaptive immune responses to 
maintain homeostasis. Respiratory epithelial cells communicate with both innate and 
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adaptive arms of the immune system to both alert the immune system to environmental 
stimuli and repair host damage. 
The respiratory mucosa contains resident immune cells that monitor the airways 
for foreign antigens. These immune cell types will be introduced briefly below, and their 
specific functions during influenza infection and pollutant exposures will be detailed later 
in this chapter. Respiratory DCs lie basolateral to respiratory epithelial cells in the lamina 
propria throughout the airways. DCs maintain constant contact with respiratory epithelial 
cells, and their “fingerlike” projections can penetrate between tight junction epithelial 
cells barriers to directly sample the airways for pathogenic antigens (1; 2). Intraepithelial 
lymphocytes, or γδ T cells, are present within the epithelium and can play both innate and 
adaptive roles in respiratory infections. Immune cell phenotypes of the airway lumen 
itself vary from the proximal to distal airways. Neutrophils (3), acute inflammatory cells 
that migrate to the site of infection to kill invading pathogens are the major cell types in 
the nasal lavage, or saline washes of the nasal cavity. Eosinophils, basophils, and mast 
cells have also been identified in the nasal lavages of allergic individuals (4). Within the 
bronchial airways, there may be a different range of leukocytes including 
monocytes/macrophages, neutrophils, natural killer (NK) cells, and DCs (5). In 
particular, alveolar macrophages are major cell types present at baseline within the lower 
airways that clear the alveloli through phagocytosis of foreign particles and antigens (6; 
7). Thus, although respiratory DCs are located throughout the basolateral epithelium, the 
cell types within the airway lumen that patrol to react against foreign particles and 
pathogens may vary from the upper to lower airways.  
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Besides initiating direct responses to pathogens, the cells of the respiratory 
mucosa participate in a complex crosstalk. This interplay between the airway epithelium 
and resident immune cells plays a crucial role in modifying the epithelium’s response to 
antigens and pollutants. As the main surface cell type within the respiratory mucosa, 
respiratory epithelial cells act as “switchboards” which through physical cell-cell 
interactions and the secretion of soluble immune mediators initiate and regulate immune 
defense throughout the airways. This communication is not one way, and regulatory 
cytokines secreted by activated immune cells act in turn upon epithelial cells and other 
immune cells to affect the balance between beneficial inflammatory and antiviral immune 
activation, and bystander damage to the airways.  
Respiratory Mucosal Responses to Influenza Infection 
Epithelial Cells Initiate and Regulate Influenza Immune Responses 
Respiratory epithelial cells are the preferential host cell type targeted by influenza 
virus and activate signaling cascades that both transmit “danger” to nearby epithelial cells 
and secrete chemokines to attract immune cells to the site of infection. Influenza virus is 
a negative strand RNA virus from the orthomyoxviridae family. Hemagglutinin (HA), an 
influenza viral surface protein, is cleaved by either soluble or membrane bound 
respiratory serine proteases (8). Cleavage of HA allows: 1) its subunit HA1 to bind to α2-
6 linked sialic acids on ciliated respiratory cells and 2) its subunit HA2 to fuse the viral 
envelope with the cellular membrane. Thus, the influenza virus enters the cell through 
endocytosis and proceeds through its life cycle (8). Influenza activates the innate immune 
signaling pathways of the respiratory epithelium and stimulates the generation of 
cytokines and chemokines (9). Pattern recognition receptors like toll-like receptor (TLR) 
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3 and retinoic acid inducible gene-1 protein (RIG-I) recognize viral RNA and activate 
nuclear transcription factors like nuclear factor κB (NF-κB), interferon regulatory factor 
(IRF) 3, and IRF7 in epithelial cells. Activation induces the production of anti-viral Type 
I interferons (IFNs) α/β that help prevent further viral infection in epithelial cells. The 
secretion of antiviral type I IFNs is a broad spectrum signal that spans several cell types 
and can alert neighboring epithelial cells, DCs, and T cells (10) alike to the presence of a 
viral infection. See Figure 2. Epithelial cells also secrete cytokines and chemokines such 
as regulated upon activation, normal T cell expressed and secreted (RANTES, CCL5), 
interferon gamma-induced protein 10 kDa (IP-10, CXCL10), interleukin (IL) 1β (IL-1β), 
interleukin 6 (IL-6), and IL-8 which recruit additional immune cells such as neutrophils, 
NK cells, and T cells that clear respiratory viruses. Mechanisms of eliminating viruses 
from the airways include neutralizing the pathogen directly through antibody-mediated 
opsonization and phagocytosis by neutrophils and macrophages. Pathogens are also 
neutralized indirectly by killing virus infected host cells through antibody-dependent 
cellular cytotoxicity (NK cells, cytotoxic T cells), lysis of cells through complement 
activation, and recognition of specific virus sequences on host cells and subsequent 
induction of apoptosis (cytotoxic T cells). Both innate and adaptive immune cells work 
together to eliminate viruses and repair respiratory epithelia.  
DCs Act As Liasons Between Innate and Adaptive Immune Systems During Influenza 
Infection 
DCs are professional antigen presenting cells that monitor host cells for display of 
foreign antigens from infected host cells. DCs phagocytose and process these antigens to 
fulfill the pivotal task of mobilizing both innate and adaptive immune cells by secreting 
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chemokines CXCL16, macrophage inflammatory protein 2α (MIP2α, CXCL2), CXCL1, 
macrophage inflammatory protein 2β (MIP2β, CXCL3) and IP-10 to attract neutrophils, 
cytotoxic T cells and NK cells, and by secreting IL-8, RANTES, and IP-10 to attract 
memory T cells (11). Activated DCs also upregulate expression of maturation receptors 
CD80, CD86, and HLA-DR to aid in antigen presentation and provide co-stimulatory 
signals to T cells during influenza infection (12). DCs migrate to peripheral lymph nodes 
to initiate an adaptive T cell response by activating influenza specific CD4+ and CD8+ T 
cell clones and supporting clonal expansion of naïve T cells via autocrine IL-2 production 
(13). DCs can also enhance T cell responses through production of IFN regulated 
chemokines such as CXCL9, IP-10, and CXCL11 to drive a Th1 CD4 T cell response and 
expand activated cytotoxic CD8 T cell pools (13). Along with non-professional antigen 
presenting cells, such as B lymphocytes, DCs activate memory T cell pools for specific 
antigens (14). However, these memory T cells require less co-stimulatory activation and 
generally proliferate faster than naïve T cells to attain their effector functions of 
cytotoxicity and cytokine secretion within 24 h (14). Along with the B cell antibody 
response, the T memory cell response to influenza infection constitutes the adaptive 
immune response to vaccination and protects against subsequent infections.  
NK Cells Communicate with Other Respiratory Mucosal Cells During an Influenza 
Infection 
NK cells perform essential functions such as killing virus infected epithelial cells 
and secreting cytokines to regulate innate and adaptive immune responses (15). NK cells 
have inhibitory activation receptors that recognize “normal” self antigen on host cells 
(15). Absence of these normal antigens on epithelial cells will reverse the receptors’ 
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inhibitory effects and lead to NK cell activation (15). In this way, NK cells are on 
constant patrol in the epithelium for virus-infected as well as transformed tumor cells. 
NK cells play important roles in respiratory viral infections. Young mice depleted of NK 
cells prior to influenza infection have increased weight loss and higher lung viral titers 
(16). In addition, studies have shown that NK cell activating receptor Ncr1 on NK cells 
protects against lethal influenza infections in mice (17). In addition, the loss of NK cell 
function by genetic defects is associated with recurrent viral and bacterial respiratory 
infections in humans (5). NK cells interact directly with epithelial cells, DCs, and 
intraepithelial lymphocytes of the respiratory epithelium during both homeostatic 
conditions as well as during an influenza infection. Cytotoxic NK cell activity is directly 
modulated by both the influenza virus, which binds to natural killer cell related protein 44 
and 46 (NKp44 and NKp46) receptors on NK cells (18), as well as by cell-cell 
interactions and exogenous cytokines. In particular, NK cells and DCs engage in a 
mutually activating crosstalk (19). Type I IFNs secreted by DCs activate NK cells, and 
IFNy secreted by NK cells activates DCs. The receptors UL16 binding protein (ULBP) 1-
3 on DCs ligate and activate NK cell activating receptors (NKG2D), indicating that direct 
cell-cell communication can enhance NK cell cytotoxic activity. In addition, ULBP1 and 
ULBP2 on DCs can be upregulated by TLR3 stimulation (20), suggesting that DCs may 
respond to influenza infections by increasing their ability to communicate with NK cells. 
NK cell activation during influenza infection is also dependent upon “wireless” 
communication, i.e. cytokine secretion from DCs and epithelial cells (19; 21). It has been 
suggested that CD56
dim
 CD16(+) cytotoxic NK cells in the respiratory epithelium arise 
from CD56
bright 
CD16(-) cytokine secreting NK cells that partially mature on exposure to 
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a pathogen through activation by DC-derived Type 1 IFNs, IL-12, and IL-15 (22). For 
example, DC-dependent production of IFNα and IL-12 increased NK cell cytolysis, 
upregulated CD69 expression, and increased IFNγ production in NK cells (23). Thus, NK 
cell cytotoxic and cytokine secreting activities may play important roles in respiratory 
infections. My own research has demonstrated that NK cells in the nasal cavity play 
important roles during responses to respiratory viral infections.  
At baseline and during influenza infection, epithelial cells, NK cells, DCs, and 
intraepithelial lymphocytes can communicate through NKG2D signaling. See Figure 2. 
During immune responses, epithelial cells as well as DCs upregulate “stress” induced 
NKG2D ligands like MHC class I polypeptide-related sequence A (MICA) and B 
(MICB) as well as ULBP1-4 that signal to both NK cells and γδ T cells (24). Expression 
of MICB is also upregulated on influenza infected macrophages (25). This NKG2D 
mediated activation induces additional secretion of chemotactic or proinflammatory 
cytokines to induce NK cell targeted killing (24). Normal human bronchial epithelial 
cells (NHBEC) express little MICA/B or ULBPs1-4 on the extracellular surface until 
treatment with 0.3mM H2O2, an inducer of oxidative stress, possibly through the 
activation of extracellular signal-related kinases (ERK) signaling pathways (26). In 
contrast, other studies have shown that NKG2D ligand expression is constitutive on 
healthy cell types including T cells, monocytes, and DCs (27). In fact, others have shown 
that NHBEC at baseline have significant expression of MICA/B which mediates 
allogeneic cytolysis by CD8+ T cells (28). Tumor cells have developed mechanisms to 
avoid NK cell and cytotoxic lymphocyte immune-surveillance by cleavage of membrane 
bound MICA by a disintegrin and metalloproteinase (ADAM) proteases (29). In this way, 
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soluble MICA has been associated with tumors. NKG2D signaling is a common 
activation mechanism that links epithelial cell, DC, NK cell, and T cell immune 
responses.  
γδ T cells Play Important Roles in Initiating and Regulating Immune Responses During 
an Influenza Infection 
γδ T cells, or intraepithelial lymphocytes, are at their highest percentages in 
epithelial tissues. Like DCs and NK cells in the respiratory epithelium, γδ T cells act as 
bridges between innate and adaptive immunity by regulating both arms of the immune 
system. A recent review by Bonneville et al summarizes current knowledge about γδ T 
cell locations, activation, and effector functions (30). Their presence in mucosal epithelia 
allow them to quickly respond to assaults and sense “danger” from nearby cells through 
recognition of stressed cell ligands and activation by proinflammatory cytokines in the 
epithelia microenvironment (30). γδ T cells recognize these signals through TLR, T cell 
receptor (TCR), or NK cell receptor (i.e. NKG2D) signaling. γδT cells express NKG2D, 
and therefore can be activated by NKG2D ligands like MICA/B and ULPBs (31) on 
either stressed epithelial cells or activated respiratory DCs. For example, ULBP4 binds to 
Vγ9/Vδ2 TCR and induces cytolytic activity (32). Some stress ligands recognized by the 
γδ TCR itself include CD1c on DCs or macrophages and viral glycoproteins (30). γδ T 
cells can be indirectly activated by TLR stimulation on DCs (in the case of influenza 
infection, TLR3 stimulation) through the DC mediated secretion of type I IFNs, TNF, and 
IL-12 (30). Functions of γδ T cells include immediate killing of virus infected or tumor 
transformed epithelial cells through either conventional T cell cytolysis (Fas signaling) or 
NK cell cytolysis (perforin/granzymes) (30). The ability of γδ T cells to kill in a T cell 
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mediated fashion without thymus selection for specific antigens emphasize that these 
transitional T cells defy traditional innate or adaptive labels (30). Like other innate 
immune cells, upon stimulation by epithelial cells or DCs, γδ T cells secrete cytokines 
and chemokines such as IL-17, IFNγ and monocyte chemotactic protein 1 (MCP-1, 
CCL2) to promote neutrophil, DC, and macrophage activation (30). γδ T cells can 
regulate immune responses in the respiratory epithelium to promote homeostasis. γδ T 
cells can either directly kill or, through secretion of IL-10 and transforming growth factor 
β (TGFβ), can suppress activated DCs, macrophages, neutrophils, as well as conventional 
T cells (30). γδ T cells also regulate epithelial cell repair. γδ T cells in the epithelium 
express epithelial cell tight junction proteins like E-cadherin and occludin that are 
upregulated by TCR engagement (30). During wound repair, intradermal γδ T cells 
secrete epithelial cell growth factors insulin-like growth factor 1 (IGF1). In this manner, 
γδ T cells can regulate and enhance barrier function in the epithelium (30). This function 
could be particularly important in oxidant air pollutant exposure which disrupts 
respiratory epithelial cell tight junctions (33-35).  
γδ T cells are necessary for successful resolution of many respiratory infections. 
γδ T cell deficient mice infected with Nocardia asteroides have decreased survival by 14 
days post infection (36) whereas in wildtype mice Nocardia asteroides infection induces 
γδ T cell infiltration into the lung within 5 days (37). Mice infected with influenza virus 
show  infiltration of γδ T cells into the BAL by 10 days post infection (38; 39) and these 
T cells are positive for variable (V) γ chains 1,2, and 4 (40). Vγ9Vδ2 TCR cells isolated 
from the peripheral blood of humans are capable of killing influenza-infected 
macrophages (41). γδ T cell deficient mice depleted of CD4 and CD8 T cell populations 
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have decreased survival following H3N2 influenza immunization compared to γδ T cell 
deficient mice with no conventional T cell depletion, indicating that γδ T cells and 
conventional T cells may have functional redundancy (42). Therefore, γδ T cells play 
important roles as cytotoxic lymphocytes within the airways during respiratory 
infections.  
Through cytokine secretion and receptor mediated interaction, the epithelial and 
immune cells of the respiratory mucosa communicate during influenza infections. These 
interactions are summarized below in Figure 3. The following will detail current 
knowledge on the effects of cigarette smoke (CS) exposure on respiratory immune cells 
and their responses to influenza infection. 
Cigarette Smoking Increases Risk of Influenza Infection  
Cigarette smoke exposure is associated with an increased risk of viral infections, 
including influenza (43)(44)(45). Following the 1968 influenza A Hong Kong epidemic, 
Finklea et al. reported that smokers who smoked more than 21 cigarettes per day were 
subject to a 21% increase in clinical influenza incidence and had increased illness 
severity compared to nonsmokers (46). Subsequent epidemiological studies have 
demonstrated that cigarette smoking leads to increased incidence and severity of 
influenza infection in multiple populations including female US military recruits (43), 
male Israeli soldiers (44) and senior citizens in assisted living communities (45; 47). A 
2004 meta-analysis confirmed that along with influenza infections, smokers have an 
increased risk for invasive pneumococcal disease and tuberculosis (48). Combined with 
evidence that smokers have lower influenza vaccination rates than nonsmokers, the 
increased influenza infection risk becomes an even more significant public health issue 
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(49). Because CS exposure is associated with susceptibility to respiratory infections, 
smokers and nonsmokers exposed to secondhand smoke (SHS) represent populations 
vulnerable to formidable illnesses like pandemic influenza and constitute a significant 
public health burden. My dissertation research adds to the body of literature that 
demonstrates cigarette smoke affects influenza induced immune responses. 
Although it is recognized that CS is a risk factor for influenza infection, the 
underlying mechanism is likely multifactorial and is not well understood. Because both 
respiratory viruses and pollutants like CS interact initially with mucosal immune cells in 
the airway epithelium, the following will focus on the effects of CS on mucosal immunity 
in the respiratory tract during an influenza infection.  
Effects of Cigarette Smoke on Influenza Infection in the Respiratory Mucosa 
Cigarette Smoke Exposure Modifies Overall Influenza Immune Response 
In animal models, CS exposure alters influenza induced immune responses. 
BALB/c mice exposed to 9 cigarettes per day for 4 days followed by influenza infection 
have increased inflammatory responses, greater viral titers and worse lung pathology, but 
decreased IL-6, IL-1β, IP-10, granzyme B, and granzyme K immune responses (50). In a 
similar study, C57BL/6J mice exposed to 1 cigarette per day for 1 week and then exposed 
to 3 cigarettes per day for an additional week followed by stimulation with 
polyinosinic:polycytidylic acid (poly I:C), which mimics double stranded RNA, have 
enhanced airway cellular infiltration, IL-18, IFNγ, Type I IFNs and IL-12/23p40 (51). CS 
alone may have differential effects in the upper and lower airways. C57BL/6 mice 
exposed to subacute levels of CS have increased inflammatory responses and neutrophil 
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influx in both the upper and lower airways (52). However, following chronic CS 
exposure, inflammatory responses decrease in the upper airways but remain elevated in 
the lower airways (52). Thus, the nature of CS induced effects in whole animal models 
may vary based on length of exposure, exposure regimen, as well as the airways sampled.  
Cigarette Smoke Exposure Modifies Epithelial Cell Antiviral Defenses 
CS exposure alters inflammatory responses in human airway epithelial cells. Our 
laboratory has previously shown that nasal epithelial cells from smokers infected with 
influenza both in vivo and ex vivo had suppressed influenza induced activation of IRF7 
and subsequent IFN-stimulated responses (53). Other studies have demonstrated that CS 
exposure augments human epithelial cell responses to other common respiratory virus 
infections. NHBEC pretreated with CS extract (CSE) and infected with human rhinovirus 
(HRV) 16 have suppressed IP-10 (54; 55) and RANTES (55) production. Janus 
kinase/signal transducers and activators of transcription (Jak/STAT) activation could play 
a role in this mechanism because CSE inhibits STAT1 phosphorylation in response to 
poly IC (55) and IFNγ (56). In contrast, CSE enhances rhinovirus-induced secretion of 
IL-8 from airway epithelial cells (54; 57). CS decreases apoptosis and increases necrosis 
in airway epithelial cells in response to respiratory syncytial virus (RSV) infection (58) 
which could explain the enhancement of proinflammatory cytokine IL-8. Thus, CS 
exposure can suppress antiviral but increase proinflammatory responses to respiratory 
viruses in respiratory epithelial cells.  
Cigarette Smoke Exposure Modifies DC and Downstream Adaptive T Cell Function 
CS exposure alters respiratory DC function. BALF DCs from smokers have 
increased expression of CD80, CD86, and CD1a with a decreased expression of the 
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lymph node homing receptor c-c chemokine receptor 7 (CCR7) (59). In contrast, sputum 
DCs from smokers exhibit decreased maturation markers CD83 and DC-lysosome 
associated membrane protein (DC-LAMP) compared to both before smoking cessation 
programs as well as to never smokers (60; 61). Smokers with chronic obstructive 
pulmonary disease (COPD) also have decreased numbers of bronchial mucosal DCs 
compared to nonsmoking controls (62; 63). The effect of CS exposure on pulmonary DC 
numbers in mice is unclear. Mice chronically exposed to 5 cigarettes per day, 5 days per 
week for 24 weeks had increased DCs in the airways and lung parenchyma with 
increased expression of CD40 and CD86 that correlated with alveolar wall destruction 
(64). Conversely, mice exposed to 4 cigarettes per day, 5 days a week for 4 weeks had 
decreased numbers of DCs in the lung but similar antigen induced migration to the lung 
(65). Although whether or not absolute numbers of DCs in the lung are augmented by CS 
exposure is not understood, CS exposure may potentially alter DC co-stimulatory 
molecules.  
CS exposure alters normal T cell function by decreasing pathological T helper cell 
1 (Th1) responses and increasing T helper cell 2 (Th2) allergic responses. CS extract 
inhibited lipopolysaccaride (LPS) induced Th1 stimulation of DCs by decreasing IL-
12p70 secretion (66) and LPS-induced expression of CD40, CD80, CD86, and CCR7 on 
DCs (67). Treatment with antioxidants n-acetylcysteine (NAC) and catalase reversed this 
IL-12p70 suppression (66). CS exposure in mice also suppressed ovalbumin induced 
CD80, CD86, and MHC Class II maturation of lung DCs as well as decreased the ability 
to these cells to stimulate IL-2 production and CD4 T cell proliferation ex vivo (65). CS 
exposure potentially alters T cell proliferation through DC modification.  
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CS exposure may enhance cytotoxic CD8 T cell function and NKG2D ligand 
expression. CSE exposure of mouse bone marrow DCs increased CD8 and decreased 
CD4 T cell proliferation in a mixed lymphocyte reaction (68). CS exposure of mice also 
may enhance cytotoxic lymphocyte activity by enhancing expression of NKG2D ligand 
retinoic acid early transcripts-1 (RAET1) (69). In humans, smoking and COPD enhances 
NKG2D ligand MICA in the bronchial epithelium (69). Consequently, conventional 
cytotoxic lymphocytes in the bronchial epithelium positive for CD3, CD8, and NKG2D 
were enhanced in smokers compared to nonsmokers (70). What this role of sustained 
NKG2D mediated CD8 cytotoxic lymphocyte activation plays in smokers during the 
course of a respiratory virus infection is unknown, especially because enhanced NKG2D 
ligands on the airway epithelium could activate NK cells as well as T cells. Thus, CS may 
alter the CD8 T cell activity either through DC or NKG2D ligand mediated changes.  
The effects of CS exposure on adaptive memory response to influenza infection 
are unclear. The generation of appropriate memory T and B cell responses depend on DC 
mediated antigen presentation to naïve T cells. However, the effects of CS exposure on 
specific memory T cell responses are unknown. CS exposure may not alter the B cell 
memory response as the levels of circulating influenza specific antibodies in either 
humans (71-73) or animals (74) exposed to CS prior to influenza infection remain 
unchanged. Therefore, it is likely that CS-induced alterations in innate immune responses 
may play a greater role than adaptive memory responses in susceptibility to viral 
infections. 
Cigarette Smoke Exposure Modifies NK Cell Function 
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CS exposure impacts NK cell immune activity. NK cell numbers and activity 
were decreased in cigarette smokers (75-79), and smokers who quit smoking for 31 days 
had elevations in cytotoxic NK cell levels (80). CS exposure suppressed NK cell 
activation and decreased cytolytic activity and CD69 expression in mice (81). In a 
melanoma tumor challenge model, CS exposure decreased NK cell activation and 
cytolytic activity, resulting in increased tumor incidence (81). CS-conditioned media 
decreased NK cell cytotoxicity and perforin expression in peripheral blood mononuclear 
cells (PBMC) (82). In addition, CS-conditioned media decreased poly I:C induced 
increases in NK cell cytotoxicity and CD69 expression in PBMC (83). This NK cell 
suppression was IL-15 dependent, indicating that IL-15 producing DCs or monocytes 
within the PBMC population could be responsible for this suppression, underscoring how 
communication between immune cells can affect antiviral responses (83). Decreased NK 
cell activity in humans is linked to recurrent pathogenic infections (5) and could be 
partially responsible for why individuals exposed to cigarette smoke have overall 
decreased immune responses to respiratory viral infections (48). However, in the context 
of COPD, which is associated with chronic cigarette smoking, the role of NK cells is 
unclear. Lung leukocytes from chronic CS exposed mice stimulated with poly I:C ex vivo 
had enhanced NK cell production of IFNγ compared to air controls (84). This could be 
due to CS-induced upregulation of NKG2D ligands on pulmonary mouse epithelium (69). 
Thus CS exposure may have opposing effects on cytolytic and NKG2D activation on NK 
cells. Whether and how NK cells are modulated in smokers in the context of viral 
infections, specifically influenza, is unknown. 
Effects of Other Air Pollutants on Influenza Infection 
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Similarities Between Cigarette Smoke, Second Hand Smoke, Diesel Exhaust, and 
Biomass  
Besides cigarette smoke, there are many other air pollutants sharing similar 
chemical features that can affect respiratory health. CS, diesel exhaust (DE), and biomass 
fumes (dung, wood smoke) are all products of incomplete combustion of organic 
materials. Nonsmokers exposed to SHS and active smokers are exposed to analogous 
chemical pollutants, such as polyaromatic hydrocarbons (PAHs), although the doses and 
exact compositions can vary (85). Thus, many air pollutants share similar chemical 
compositions that include PAHs, benzene, and carbon monoxide (86-88). These 
pollutants also contribute to the heterogenous composition of particulate matter (PM), 
which contains metals (Cr, Co, Ni, Mn, Zn, V, Cu, and Fe) as well as PAHs like 
benzo[a]pyrene and naphthalene (89). These different air pollutants can adversely affect 
human health through induction of oxidative stress and by increasing inflammation (89).  
Effects of Secondhand Smoke Exposure on Respiratory Viral infections 
Studies examining the effects of SHS exposure on respiratory immune responses 
to influenza and other respiratory viruses are not as numerous as CS studies but in 
general suggest that exposure to SHS is deleterious to respiratory health (90). Our own 
data demonstrated that nonsmokers routinely exposed to SHS prior to inoculation with 
live attenuated influenza virus (LAIV) had suppressed IP-10 and IL-6 responses that were 
intermediate between nonsmokers and active smokers, indicating that CS exposure may 
have a “dose dependent” effect on immune suppression (3). SHS exposure either 
prenatally, during infancy, or during both time periods decreased in vitro secretion of the 
immunoregulatory cytokine IL-10 from peripheral blood monocyte derived DCs (91). 
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SHS exposure also increased RSV infection in children (92). A study examining the 
relationship between SHS exposure and acute lower respiratory tract infection (LRI) in 
hospitalized young children indicated that while SHS was not associated with increased 
risk of RSV-LRI, infants exposed to SHS with RSV-LRI were more likely to have 
desaturating oxygen levels (93). Another study showed that RSV hospitalized infants 
exposed to SHS postnatally also had decreased oxygen saturation, which could increase 
RSV morbidity (94). In addition, smoking in the household is considered a risk factor in 
RSV-related hospitalization (95). Thus, like CS, SHS exposure can impact immune 
responses to respiratory viral infections. 
Effects of Diesel Exhaust and Particulate Matter on Influenza Infection 
Diesel exhaust, a component of PM, also alters immune responses to respiratory 
viral infections. Epidemiological studies have also indicated that increases or fluctuations 
in ambient PM levels can increase risk of respiratory infections as well as mortality from 
influenza and pneumonia (96). Animal models examining the effects of PM on 
respiratory viruses, particularly RSV, demonstrate that PM does indeed increase virus 
mortality and alters immune responses possibly through decreasing antiviral mediators, 
increasing inflammation, and inhibiting macrophage phagocytosis (96). DE is similar in 
size to fine PM, can easily travel deep into the lungs, and is a significant contributor to 
overall PM levels (96). There is a wealth of animal studies confirming that DE enhances 
susceptibility to viral infections, including data from our own group (97; 98). Taken 
together, these data suggest that like CS exposure, other ambient air pollutants have 
negative effects on respiratory virus infections.  
Effects of Particulate Matter on DC and Adaptive T Cell Function 
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Exposure to PM impacts DC and T cell respiratory responses. PM increased 
expression of CD40, CD80, and CD86 (99) and decreased TLR2 and TLR4 expression 
(100) on DCs. Stimulation of allogenic CD4+ T cells with PM treated DCs produced a 
Th2-like response with a decreased IFNy:IL-13 ratio compared with LPS stimulated DCs 
(99). In addition, PM exposed pulmonary DCs from mice stimulated naïve CD4 T cells in 
a Th2 response (101). Ultrafine carbon black particles and ovalbumin (OVA) instillation 
also enhanced DC numbers, DC co-stimulatory molecules, and T cell proliferation in 
draining lymph nodes (102). Oxidative stress as well as nuclear factor receptor 2 (NRF2), 
a master regulator of the antioxidant response, may play a role in these pollutant-induced 
changes. DCs from (NRF2)-/- mice following PM exposure had increased H2O2 
production and decreased responses of antioxidant genes (103). As a result, NRF2-/- DCs 
had a decreased ability to phagocytose antigen with an increased release of 
proinflammatory cytokines IL-18 and TNFα (103). PM exposure to NRF2-/- DCs 
resulted in enhanced secretion of Th2 cytokines IL-5 and IL-13 compared to wildtype 
mice (103). Thus PM can affect DC and downstream T cell responses in an oxidative 
stress dependent manner.  
Effects of Diesel Exhaust on DC and Adaptive T Cell Function 
There are extensive data on the effects of DE particles (DEP) on DC function 
using both in vivo and in vitro exposure models. DEP modify characteristic DC 
responses. DEP alone increased expression of co-stimulatory molecules CD40, CD80, 
CD83, and CD86 and increased phagocytic capability and expression of the endocytosis 
receptor CD206 on DCs (104) although others have reported no changes in co-
stimulatory marker expression (105). DEP also modulate DC responses to LPS. DEP 
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alone decreased LPS induced TLR2 and TLR4 expression on DCs (104). DEP suppressed 
LPS induced expression of CD83 and MHC Class II on DCs and secretion of IL-12 
through activation of the Nrf2 signaling pathway (106) although others have reported that 
DEP enhanced LPS induced CD83 expression on DCs (105). Thus DEP exposure 
modifies DC maturation markers and LPS induced DC activation. 
DEP exposure modulates not only expression of DC maturation markers but also 
DC activation and downstream T cell responses. DCs when pretreated with DEP and then 
stimulated with CD40 ligand and IFNy secreted less IL-12 and TNFα in an 
immunosuppressive effect (107). DEP also modified DC ability to orchestrate a T cell 
response. In co-cultures with DEP treated DCs and allogenic CD4+ T cells, DEP 
enhanced IL-13, IL-12, and IFNγ (104), and IL-10 (106) from stimulated T cells. DEP 
exposure models increased Th2 cytokine responses. Exposure to both DEP and 
ovalbumin in mice enhanced the ability of splenic mononuclear cells to generate IL-4, IL-
5, and IL-15 following ex vivo antigenic stimulation (108). The combination of repeated 
exposures to both DEP and OVA increased MHC Class II markers and DC maturation 
markers CD11c, CD80, and CD86 as well as B cell marker CD19 on whole lung cells 
(108). Therefore, DEP can affect the ability of DCs to initiate a T cell response. 
The mechanism underlying DEP enhancement of Th2 allergic responses has been 
studied using co-culture systems of DCs and airway epithelial cells (2; 109; 110). 
Cultured DCs are applied basolaterally to human airway epithelial cells grown on 
membrane support and cab access deposited particles in the epithelium through inter-
epithelial projections (110). Fine particle deposition increases DC projections into the 
lumen (2). Exposure of pollutants to the epithelium induced the release of factors 
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promoting DC development. Ambient PM enhanced release of MIP-3α, a chemokine that 
causes DC migration, from bronchial epithelial cells (111). DEP exposure to human 
bronchial epithelial cells increased DC CD83 expression and enhanced T cell 
proliferation in a granulocyte-macrophage colony stimulating factor (GM-CSF) 
dependent manner (112). Thymic stromal lymphopoeitin (TSLP) release from DEP 
treated human bronchial epithelial cells induced Th2 DC polarization (113). Therefore, 
DEP can induce the release of cytokines from airway epithelial cells that activate DCs in 
a Th2 dependent manner.  
Effects of Biomass on Respiratory Infections 
Besides SHS, other indoor pollutants can contribute to deleterious health effects. 
Solid fuels, such as biomass, which includes wood, dung, and crop remains, and coal are 
primarily used for both cooking and heating in up to 90% of households in rural areas of 
developing countries and are significant contributors to indoor air pollution (114). These 
indoor kitchens are poorly ventilated and typically expose women and young children to 
high levels of PM, carbon monoxide, nitrogen oxides, and PAHs for 3 to 7 hours daily for 
years, and the overall health consequences of these exposures are comparable to SHS 
(114; 115). A meta-analysis determined that although the link between solid fuel 
exposure and RSV is unclear, solid fuel exposure increases the risk of pneumonia in 
young children (116). Solid fuel exposure is also associated with diseases like COPD in 
women (117; 118), chronic bronchitis in women (118) and acute respiratory infections in 
children (117; 118). Consequently, reducing biomass exposures in these rural populations 
could benefit respiratory health. 
Effects of Other Air Pollutants on NK and T Lymphocyte Function 
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Data on the effects of other oxidant airway pollutants such as DEP, PM, and 
biomass on NK and T cell function are limited. BALB/C mice injected with DEP 
followed with LPS treatment had decreased splenic NK and NKT cell mediated 
production of IFNγ (119). Daily wood smoke exposure for 6 months did not alter 
expression of CD3, CD4 or CD 8 on T cells, Mac-1 on macrophages, CD19 on B cells, or 
CD16 on NK cells (120). However, the effects of wood smoke on concanavalin A 
induced T cell proliferation were inconclusive as low levels of wood smoke enhanced 
proliferation (100 μg/m3) whereas high levels of wood smoke (<300 μg/m3) suppressed 
proliferation (120). The phenomenon that low doses of PAHs enhance immune responses 
whereas high doses of PAHs are immunosuppressive has been reported in mouse uterine 
NK cells from placental exposed PAHs (121). Thus, the effects of DEP and wood smoke 
on lymphocytes in the respiratory epithelium beg elucidation and perhaps share common 
mechanisms with CS induced immune suppression. 
Summary 
It is evident that ambient air pollutants, especially CS, increase susceptibility to 
respiratory viruses. This susceptibility most likely is due to CS mediated suppression of 
innate immune antiviral responses. Suppression may initiate in respiratory epithelial cells 
and be transferred to other respiratory immune cells like DCs, NK cells, and γδ T cells. In 
the following chapters, I will describe my research into how CS may impact respiratory 
mucosal responses to influenza infection in these specific immune cell types. These data 
underscore the need to limit CS exposure as well as devise therapeutics to prevent CS 
induced disease.  
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Figure 1. Immune Cells of the Respiratory Mucosa. In the apical airway lumen, 
lymphocytes patrol the airways and interact with respiratory viruses. Underlying 
respiratory epithelial cells communicate directly with these viruses as well as 
with activated airway leukocytes. Basolateral to respiratory epithelial cells lie 
dendritic cells that patrol the epithelium for foreign antigens and can directly 
sample the airways with dendritic-like projections. Intraepitheial γδ T 
lymphocytes are located throughout the respiratory mucosa and regulate 
immune responses.  
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Figure 1. Immune Cells of the Respiratory Epithelium 
In the apical airway lumen, leukocytes patrol the airways and interact with respiratory 
viruses. Underlying spiratory epithelial cells communicate directly with these viruses as 
well as with activated airway leukocytes. B sol teral to respiratory epithelial cell  lie 
dendritic cells that atrol th  epithelium for foreign ntigens and can dir ctly ample the 
airways with dendritic-like projections. Intra-epithelial γδ T lymphocytes are located 
throughout the respiratory mucosa and regulate immune responses.   
23 
 
Figure 2. Respiratory Immune Cells Communicate Via NKG2D Signaling. 
NEC and DCs express NKG2D ligands MICA, MICB, and ULPB1-4 at baseline and 
during cellular stress, including viral infections. NK cells and T cells recognize these 
ligands via NKG2D activating receptors to enhance cytotoxicity and cytokine secretion.  
 
24 
 
Figure 3. Nasal Mucosal Cells Communicate During Influenza  
Induced Immune Responses. In the apical airway lumen, 
natural killer (NK) cells patrol the airways for pathogens such 
as the influenza virus and monitor nasal epithelial cells  (NEC) 
for markers of infection. NEC secrete chemokines RANTES 
and IP-10 to attract and activate additional NK cells. 
Respiratory dendritic cells (DCs) lie basolateral to NEC and 
monitor NEC for display of viral antigens. Their “dendritic-like” 
projections can directly sample the airways. DCs secrete type I 
IFNs α/β to activate both NEC and NK cells. In turn, NEC-
derived IFN α/β and NK cell-derived IFNγ activate DCs. NEC 
secrete T cell chemokines RANTES and IP-10 to attract 
intraepithelial γδ T cells. During an immune response, γδ T 
cells can secrete IL-10 and TGFβ to suppress DC immune 
responses or secrete IL-17 to enhance NEC inflammation.  
The effects of cigarette smoke (CS) on these interactions will 
be explored. 
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Figure 3. Nasal Mucosal Cells Communicate During Influenza Infections. 
In the apical airway lumen, NK cells patrol the airways for pathogens such as the 
influenza virus and onitor nasal epithelial cells (NEC) for arkers of infection. NEC 
secrete chemokines RA TES and IP-10 to attract and ctivate additional NK cells. 
Respiratory DCs lie basolateral to NEC and monitor NEC for display of viral antigens. 
Their “dendritic-like” projections can directly sample the airways. DCs secrete type I 
IFNs α/β to activate both NEC and NK cells. In turn, NEC-derived IFN α/β and NK cell-
derived IFNγ activate DCs. NEC secrete T cell chemokines RANTES and IP-10 to attract 
intraepithelial γδ T cells. During an immune response, γδ T cells can secrete IL-10 and 
TGFβ to suppress DC immune responses or secrete IL-17 to enhance NEC inflammation.  
 
  
 
 
CHAPTER 2 
EPITHELIAL CELLS FROM SMOKERS MODIFY DENDRITIC CELL RESPONSES 
TO INFLUENZA INFECTION  
Abstract 
Rationale: Epidemiological evidence suggests that cigarette smoking is a risk factor for 
influenza infection, but the mechanisms underlying this susceptibility remain unknown. 
To ascertain if airway epithelial cells from smokers have a decreased ability to 
orchestrate an influenza-induced immune response, we established a model utilizing 
differentiated NEC (nasal epithelial cells) from nonsmokers and smokers and then co-
cultured NEC with peripheral blood monocyte-derived dendritic cells (mono-DCs) from 
nonsmokers.  
Methods: NEC/mono-DC co-cultures were infected with influenza A virus and analyzed 
for influenza-induced immune responses 24 h post infection.  
Results: We demonstrated that NEC from smokers, as well as mono-DCs co-cultured 
with NECs from smokers, have suppressed influenza-induced interferon related proteins 
IRF7, TLR3, and RIG-I, likely due to suppressed IFNα production from smoker NECs. 
Furthermore, NEC/mono-DC co-cultures using NEC from smokers have suppressed 
levels of T cell/NK cell chemokine IP-10 following influenza infection, indicating that 
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NECs from smokers may skew early influenza-induced Th1 responses. In contrast, we 
demonstrated that NEC/mono-DC co-cultures using NEC from smokers had increased 
influenza-induced levels of the Th2 chemokine TSLP. In addition, NEC from smokers 
cultured alone had increased influenza-induced levels of the Th2 chemokine TARC.  
Conclusions: Using this model, we have demonstrated that following influenza infection, 
NEC obtained from smokers create an overall cytokine microenvironment that suppresses 
the interferon-mediated Th1 response and enhances the TSLP-TARC mediated Th2 
response to potentially modify DC responses. Smoking-induced alterations in the 
Th1/Th2 balance may play a role in developing underlying susceptibilities to respiratory 
viral infections as well as promote the likelihood of acquiring Th2 pro-allergic diseases. 
 
27 
Introduction 
Epidemiological studies demonstrate that smokers are at increased risk for 
influenza infections (43-46). However, mechanisms mediating enhanced susceptibility to 
viral infections seen in smokers are not known. In human (71-73) and animal (74) models 
of influenza, adaptive humoral immunity, as measured by influenza specific antibody 
production is unaffected by CS exposure. Therefore, this chapter focuses on the effects of 
CS exposure on innate immune mechanisms during an influenza infection.  
It has been shown that CS exposure suppresses innate immune responses of the 
respiratory epithelium (53). Influenza virus infects epithelial cells by binding via 
hemagglutinin and entering cells via sialic acid residues utilizing endocytosis. Soon after 
infection, influenza activates the innate immune system of the respiratory epithelium and 
stimulates the generation of cytokines and chemokines (9). Pattern recognition receptors 
(PRRs) such as TLR3 and RIG-I recognize viral RNA and activate nuclear transcription 
factors like NF-κB, IRF3, and IRF7 in epithelial cells. Synthesis and binding of IRFs to 
interferon response element (ISRE) promoter regions induces the production of antiviral 
type I IFNs, for example IFNα/β, that help prevent further viral infection. We have 
previously shown that IRF7 expression is decreased in nasal epithelial cells (NEC) from 
smokers following influenza infection, yielding suppressed type I IFN production in these 
cells (53). Similarly, CS conditioned media has been shown to inhibit IRF3, IRF7, and 
NF-kB responses to poly I:C in lung epithelial cells and fibroblasts (122). 
The interplay between the airway epithelium and resident immune cells such as 
DCs is crucial in mobilizing respiratory immune responses. Activated DCs fulfill the 
pivotal task of mobilizing both innate and adaptive immune cells by secreting 
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chemokines to attract neutrophils, cytotoxic and memory T cells, and NK cells (11). 
Specifically, DCs produce chemokines such as RANTES, CXCL9, IP-10, and CXCL11 
and drive a Th1 CD4+ T cell response to expand activated cytotoxic T cell pools (13). 
Direct infection of DCs with influenza virus has been shown to activate DC antiviral 
defenses including RIG-I, TLR3, and IRF7 (123), but whether and how signals derived 
from the microenvironment, such as surrounding epithelial cells, modifies these effects is 
not known. 
Respiratory DCs are capable of responding to not only Th1 cytokines produced 
during a viral infection, but also to Th2 chemokines produced by a dysregulated 
respiratory epithelium. TSLP is an epithelial cell-derived Th2 chemokine that 
communicates with and induces Th2 responses in DCs. TSLP acts directly on DCs to 
increase production of TARC (124), which in turn coaxes naïve T cells to secrete pro-
allergic cytokines such as IL-5, IL-4, IL-13, and TNFα which have the potential to foster 
the development of an allergic, Th2 CD4 T cell phenotype (125). Although it has been 
demonstrated that normal human bronchial epithelial cells up regulate TSLP in response 
to stimulation with the viral dsRNA mimetic poly I:C (126), it is not known how virus-
induced TSLP or TARC expression may be altered during an influenza infection in 
smokers. 
In vitro studies that treat DCs directly with CS may not provide the most realistic 
model system because signals derived from the respiratory epithelium are important in 
generating the proper microenvironment for DC maturation in vivo. To address the 
limitations of current human in vitro airway epithelia models, co-culture systems of 
airway epithelial cells and DCs have been developed to study the effects of particles on 
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the airway epithelium (1; 2; 127). These models have the potential to explore the 
mechanisms of airway epithelial and immune cell communication during immunological 
responses, including respiratory viral infections. We expanded upon these existing 
models to develop a co-culture system of human NEC obtained from nonsmokers and 
smokers and monocyte-derived DCs (mono-DCs) obtained from healthy nonsmokers to 
determine how smoking-induced changes at the level of the epithelium affects 
communication with resident immune cells.   
 
 
30 
Methods 
Culture of NEC 
NECs were obtained from smoking and nonsmoking healthy human volunteers 
and differentiated in vitro on 0.4 μM pore size membrane support as described previously 
(53). The selection criteria for subject recruitment were similar to those described 
previously (53; 128). Smoking status was assessed via questionnaire and confirmed 
through urine cotinine measurements (128). All of the smokers recruited for the study 
were current smokers.  
Culture of Mono-DCs, NEC-Mono-DC Co-Culture System and Influenza Infection 
Peripheral blood monocytes were isolated from healthy nonsmoking volunteers. 
Monocyte-derived DCs (mono-DCs) were generated by culturing peripheral blood 
monocytes with 30 ng/ml GM-CSF (Peprotech, Rocky Hill, NJ) and 30 ng/ml IL-4 
(Peprotech) for 5-7 days. Differentiation of mono-DCs was confirmed using flow 
cytometry to identify expression of DC markers CD86, CD40, CD209, HLA-DR, and 
CD11c as described in supplemental data (BD Biosciences, San Jose, CA). Our NEC-
mono-DC co-culture system is based upon a three dimensional cell culture model 
described previously (1). 1.5 x 10
5
 mono-DCs were applied to the basolateral side of 
inverted differentiated NEC grown on membrane support of approximately 1.13 cm
2
 (see 
Figure 4). Mono-DCs were adhered for two hours after which NECs were infected with 
influenza A/Bangkok/1/79 (H3N2 serotype) as described before (129). All samples were 
collected 24 hrs post infection unless otherwise indicated.  
Supernatant Cytokine Levels 
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The apical surfaces of the co-culture NECs were washed with HBSS. Apical 
washes and basolateral supernatants were collected and analyzed for cytokine secretion 
of IP-10 (BD Biosciences), RANTES, TARC, and TSLP (all R&D Systems) using 
commercially available ELISA kits. 
Analysis of mRNA From NEC and Mono-DCs 
NEC and mono-DCs were removed from the membrane and added to Trizol® 
(Invitrogen, Carlsbad, CA) for isolation of total RNA. Real-time qRT-PCR was 
performed as described previously (129), using commercially available primers and 
probes for TLR3, RIG-I, IRF7, IP-10, and RANTES (Applied Biosystems, Foster City, 
CA) 
Western Blotting 
Whole cell lysates were prepared and analyzed as described by us before (53), 
using specific antibodies to IRF7 (Santa Cruz Biotechnology, Santa Cruz, CA), or β-actin 
(1:2000, USBiological, Swampscott, MA).  
Visualization of Co-Culture System 
Co-cultures were fixed with ice cold methanol for 20 minutes. Antibodies to 
CD11c (ebioscience, San Diego, CA) and acetylated α-tubulin (Abcam, Cambridge, MA) 
were used to identify mono-DCs and cilia of NEC, respectively, followed by incubation 
with Alexa-488-conjugated and Alex-596-conjugated secondary antibodies (Invitrogen). 
Samples were visualized using a Nikon C1Si laser scanning confocal microscope and 
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images were processed using the EZ-C1 FreeViewer software (Nikon Instruments, 
Melville, NY).  
Flow Cytometery of Mono-DCs 
Mono-DCs were removed from the membrane using a cell scraper into RPMI 
media supplemented with 10% FBS. Mono-DCs were resuspended in flow staining buffer 
(DPBS supplemented with 1% FBS and 0.09% sodium azide) and stained at a density of 
1.5 x 10
5
 cells/100 ul total volume. Mono-DCs were stained according to manufacturer’s 
instructions (BDBiosciences) with CD45 (Leukocyte marker), CD86, CD209, CD11c, 
CD11b and HLA-DR (DC markers), washed with flow staining buffer, fixed with 0.5% 
paraformaldehyde, and analyzed by flow cytometry within 24 h. 
Statistical Analysis 
mRNA and mono-DC maturation data from co-culture experiments are expressed 
as fold induction over non-infected control to determine influenza-induced responses and 
analyzed using a Wilcoxon signed-rank test. Differences in influenza-induced and 
baseline responses between nonsmoker and smoker NECs were analyzed using a 
nonparametric Mann Whitney U test. Protein supernatant data were analyzed using a 2-
way ANOVA followed by a Bonferroni’s post-hoc analysis. All data were expressed as 
mean + S.E.M with p<0.05 considered to be significant.
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Results 
Development and Visualization of Co-Culture Model 
To develop mono-DCs, peripheral blood monocytes were incubated with IL-4 and 
GM-CSF and analyzed for positive expression of characteristic DC surface markers. Prior 
to co-culture with NECs, mono-DCs were analyzed by flow cytometry and shown to have 
positive expression of DC maturation markers CD11b, CD11c, CD86, CD209, and HLA-
DR (data not shown).  
To determine whether mono-DCs cells form networks on the basolateral side of 
NECs in our co-culture model, we visualized the different cell types using confocal 
microscopy. In Figure 5, the top panels show en face visualization of the apical border of 
the epithelium (left) and the mono-DCs on the basolateral side. To stain the cilia of NECs 
we used mouse anti-acetylated alpha tubulin followed by an alexa-596-conjugated 
secondary antibody (red), as demonstrated previously (129; 130). DCs were identified 
using mouse anti-CD11c followed by an alexa-488-conjugated secondary antibody 
(green). The bottom panel shows a x-y-z optical cross section of the co-culture model 
with the mono-DCs lying basolaterally to the nasal NECs, a polarization that resembles 
their in vivo orientations.  
Mono-DC Maturation in Co-Culture Model Following Influenza Infection  
To determine whether surface markers indicating DC maturation are changed in 
mono-DCs cultured with NEC from smokers and non-smokers, we analyzed surface 
marker expression of mono-DCs by flow cytometry following influenza infection. Cells 
were gated (P1) for positive expression of leukocyte marker CD45 (Fig. 6A). Mono-DCs 
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co-cultured with NECs had positive baseline expression of CD11b, CD40, CD209, 
CD11c, and CD86 (representative histograms in Figure 6B-F). Figures 6G-I show that 
influenza infection did not change expression of CD11b, CD40, and CD209 in mono-
DCs cultured with NECs from either smokers or nonsmokers. In contrast, expression of 
CD11c was only upregulated after influenza infection in mono-DCs derived from co-
cultures using NEC from non-smokers (Fig. 6J). CD86 was enhanced after influenza 
infection in mono-DCs derived from both nonsmoker and smoker co-cultures (Fig. 6K). 
However, changes in CD11c and CD86 did not appear to be robust.  
Smoker NECs Have Suppressed Anti-Viral Responses 
To determine how antiviral defense responses are modified, NEC/mono-DC co-
cultures using NECs from nonsmokers and smokers were infected from the epithelial side 
with 1 MOI influenza A virus. Total RNA was collected separately from both cell types 
24 hrs after infection and analyzed for antiviral responses. To determine whether our 
previous observation of suppressed influenza-induced IRF7 expression in NEC from 
smokers (53) could also be observed in this co-culture model, we analyzed IRF7 mRNA 
(Fig. 7A) and protein (Fig. 7B) expression in NEC from co-cultures. Similar to our 
previous study (53), influenza-induced IRF7 expression was suppressed in NEC from 
smokers. In addition to IRF7, influenza-induced expression of pattern recognition 
receptors (PRRs) is important for antiviral defense responses. Influenza infection did not 
induce TLR3 mRNA expression in NEC from smokers (Fig. 7C) and that influenza-
induced RIG-I mRNA expression was suppressed in NEC from smokers (Fig. 7D). 
Baseline expression of RIG-I, TLR3, and IRF7 was similar in nonsmoker and smoker 
NECs as shown in Table 1. 
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Smoker NECs Suppress Anti-Viral Responses In Mono-DCs  
To determine whether the changes in antiviral defense responses seen in NEC 
from smokers also lead to suppressed responses in the mono-DCs, we analyzed the same 
antiviral defense markers in the mono-DCs of the co-cultures. Influenza infection 
increased IRF7 (Fig. 8A) and RIG-I (Fig. 8B) mRNA levels in mono-DCs co-cultured 
with either NEC from nonsmokers or smokers, but this induction was significantly 
greater in mono-DCs cultured with NEC from non-smokers. Influenza infection tended to 
increase TLR3 mRNA levels of mono-DCs co-cultured with NEC from nonsmokers, 
albeit it did not reach statistical significance (p=0.06) (Fig. 8C).  
Activation of TLR3 and RIG-I prompts the production of inflammatory and 
immune mediators, including chemokines such as IP-10 and RANTES (131; 132), which 
are important for immune cell migration. Therefore, we examined the expression of these 
two chemokines in the co-cultures. Baseline expression of RANTES and IP-10 mRNA 
was similar in nonsmoker and smoker NECs from co-cultures (See Table 1). Influenza 
induced IP-10 mRNA expression was suppressed in NECs (Fig. 9A) and mono-DCs (Fig. 
9B) from co-cultures using NEC from smokers. The use of transwell inserts allows for 
separate analysis of protein secretion from the apical (upper) and basolateral (lower) 
compartments of the mono-DC/NEC co-culture system (See Figure 4), as reported 
previously (130; 133). In apical washes (Fig. 10A) and basolateral supernatants (Fig. 
10B) IP-10 secretion in influenza infected co-cultures using smoker NECs was 
suppressed compared to nonsmoker controls. Influenza infection induced RANTES 
expression in NEC from both nonsmokers and smokers (Fig. 9C), but not mono-DCs 
derived from the co-cultures (Fig. 9D). Interestingly, RANTES protein secretion was 
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increased in apical washes and basolateral supernatants from co-cultures using influenza 
infected NECs from nonsmokers but not from smokers. Overall, these data indicate that 
influenza-induced IP-10 was suppressed in both NEC and mono-DCs co-cultures using 
NEC from smokers. 
Influenza Infection Increases Th2 Chemokines In Smoker NECs  
It has been shown that CS exposure can lead to a Th2 phenotypic immune 
response (134). Therefore, after demonstrating that co-cultures using NEC from smokers 
show suppressed expression of chemokines associated with Th1 responses (i.e. IP-10), 
we determined whether chemokines associated with Th2 phenotypes were altered. We 
first analyzed the expression of TSLP, a Th2 chemokine that is secreted by NECs and is 
upregulated in mouse lungs after CS extract exposure (135). Influenza infection increased 
TSLP secretion into the basolateral supernatant in co-cultures using NEC from smokers 
compared to nonsmokers (Fig. 11A). TSLP is not detectable in the apical compartment 
(data not shown). TSLP acts upon DCs to stimulate TARC production (136). Therefore, 
we determined whether the changes in TSLP expression were reflected in increased 
TARC expression in basolateral supernatants from co-cultures using NEC from smokers. 
Overall, influenza infection did not increase TARC levels in the basolateral supernatants 
from NEC/mono-DCs co-cultures using NEC from nonsmokers or smokers (Fig. 11B), 
and TARC levels were below detection in the apical compartment (data not shown). 
Considering that mono-DCs from healthy individuals have high constitutive levels of 
TARC expression (137), it is likely that mono-DCs are heavily contributing to the overall 
high TARC levels in the basolateral supernatants. Previous studies have shown that in 
addition to DCs, TARC can be expressed in other respiratory cell types, including 
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epithelial cells (138). To further determine if influenza-induced TARC expression is 
altered in NECs from smokers alone, we designed experiments in which NECs in the 
absence of mono-DCs were analyzed. Figure 11 shows that influenza infection 
significantly increased TARC production in NECs from smokers, but not in NECs from 
nonsmokers. 
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Discussion 
Communication between DCs and other cell types during an immune response is 
crucial for DC activation, and single cell culture models using DCs cannot study this 
interaction. Our two cell co-culture model of NECs and DCs allows us to determine the 
interplay between the virally infected epithelium and DCs and also how smoking may 
interrupt this communication. Using this model, we have demonstrated that during an 
influenza infection, NEC obtained from smokers have altered communication with 
underlying mono-DCs, creating an overall cytokine microenvironment that suppresses the 
interferon mediated Th1 response and enhances the TSLP-TARC mediated Th2 response. 
We have shown here that co-culturing mono-DCs with NEC from smokers alters 
the mono-DC response to influenza infection. The nature of this communication is likely 
through “soluble mediators or cytokine secretion, although other possibilities exist. 
Activated DCs have been shown to release exovesicles, small membrane bound vesicles 
that can contain cytokine and immune receptors (139). These exovesicles are capable of 
activating TNFα pathways in airway epithelial cells in a co-culture model (140). Thus, it 
is possible in our model that NEC and mono-DCs are communicating through exovesicle 
mediated pathways. In fact, RNA-containing exovesicles have been detected in human 
NLF (141). It has also been suggested in a co-culture model of lung epithelial A549 cells 
and mono-DCs that DCs are capable of forming intraepithelial cell projections through 
the pores of the cell culture membrane to engage in direct epithelial cell-DC contact (2). 
Although we cannot rule such interactions out, due to the smaller pore size we must use 
for efficient culture of differentiated NEC (0.4 μM vs. 3.0 μM size used by Blank et al 
(2)), we doubt mono-DC projections are playing a large role in their activation and did 
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not find projections in our immunohistochemical models. Also, mono-DCs used in our 
studies do not show any markers of direct influenza infection (no detectable influenza 
HA RNA; data not shown), suggesting that they may not have access to the apical surface 
where infection is occurring. Therefore, we believe it is possible that in our model 
antiviral mediator and cytokine expression are initiated by epithelial derived cytokines 
and chemokines acting on mono-DCs. For example, NEC derived IFNs are secreted by 
infected epithelial cells (53) and can activate nearby NEC in an autocrine fashion to 
induce the expression of interferon related gene products, including TLR3 (130). 
Similarly, influenza infected NEC could also activate nearby DCs in a paracrine fashion 
via IFNα secretion to act upon mono-DC IFNα receptors, culminating in the transcription 
of IRF7, TLR3, RIG-I, and IP-10. Thus, it is possible that the reduced IFNα expression 
seen in NEC from smokers, as shown previously (53), leads to suppressed IFN-induced 
antiviral defense responses in underlying immune cells, such as DCs. Overall, these data 
demonstrate that in addition to type I IFN release and IRF7 expression (13), the 
expression of PRRs, such as RIG-I and TLR3 are suppressed in smoker NECs, 
potentially resulting in suppressed activation of resident immune cells that communicate 
with the respiratory epithelium during an influenza infection.  
Our data demonstrate that influenza-induced IP-10 expression is reduced in both 
NECs from smokers as well as mono-DCs co-cultured with NECs from smokers, thereby 
leading to overall reductions in IP-10 protein secretion in both the apical and basolateral 
compartment of the co-culture systems. During an influenza infection, IP-10 is released 
from NECs to attract lymphocytes and T cells to the site of infection (142). Smoke 
exposed mice infected with influenza have suppressed levels of whole lung IP-10 mRNA 
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with modified profiles of CD4/CD8 T cells in the BAL and draining lymph nodes (50). 
hawse have shown that smokers inoculated with LAIV have reduced IP-10 levels in nasal 
lavage fluid compared to non-smoker controls (3). Besides T cells, suppressed IP-10 
production by the respiratory epithelium could lead to suppressed recruitment of other 
immune cells like NK cells. NK cells express the IP-10 receptor CXCR3 and migrate to 
the respiratory epithelium during an influenza infection (143). Decreased IP-10 responses 
could be responsible for decreased cytotoxic NK cell numbers and could explain why 
levels of granzymes B and K, important mediators of cytotoxic NK cells, are reduced 
following influenza infection of mice exposed to CS (50).See chapter 3. Thus, reduced 
IP-10 production by either NEC or DCs after viral infections could have a significant 
impact on the ability to fight and clear the infection. Influenza infection increases 
RANTES secretion into the apical and basolateral compartments in nonsmokers not in 
smokers, although there was no overall difference in RANTES secretion between groups. 
Like IP-10, RANTES is an important chemokine that is released during influenza 
infection (142). A lack of IP-10 response in smokers may indicate that smokers NECs 
have decreased communication with immune cells and highlights the importance of non-
immune cells in orchestrating both innate and adaptive immune responses to viral 
infections.  
Cigarette smoke exposure has been shown to shift immune responses from a Th1 
to a Th2 phenotype (134). TSLP, a Th2 chemokine, is secreted by epithelial cells and 
triggers TARC expression in nearby DCs (124). TSLP in epithelial cells as well as TARC 
in DCs is upregulated with exposure to airborne pollutants including diesel exhaust (113) 
and CS extract (135). CS exposure has also been shown to upregulate TARC mRNA 
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expression in whole lungs in mice (144). We have shown here that influenza infection 
upregulates TSLP secretion in co-cultures using NECs from smokers, but not 
nonsmokers, suggesting that in smokers the activation of the TSLP pathway may be 
occurring in concert with suppression of Th1 chemokines, such as IP-10. Smoker NECs 
themselves also have elevated TARC levels, which have also been shown in the 
broncheoalveolar lavage of current and ex-smokers (145). TSLP and TARC were 
undetectable in the apical washes (data not shown), which also suggests that 
differentiated NECs may have polarized protein secretion patterns. These data are the 
first examples of TSLP and TARC upregulation in smoker epithelial cells during an 
influenza infection and suggest that in smokers Th2 chemokines that alter the viral 
immune response from a predominant Th1 phenotype to a Th2 phenotype may originate 
from both airway epithelial cells as well as myeloid cells, like DCs. 
In our model, infected NECs can communicate with underlying immature mono-
DCs through cytokine secretion. Immature DCs develop from monocyte precursors after 
treatment with GM-CSF and IL-4 and only progress to maturation through two steps: 1) 
exposure to a combination of inflammatory cytokines from the respiratory epithelium and 
2) after the acquisition of antigen with associated increases in co-stimulatory molecules 
that engage naïve T cells (146). Our model of infected NEC does produce inflammatory 
and immune activating cytokines like type I IFNs and IL-6 (53) but may not provide 
other signals like TNFα that are necessary to induce IL-12 production from mature DCs 
(147). In the case of an influenza infection, DCs are thought to process antigen through 
the phagocytosis of apoptotic cells (146). It is possible that in our model the cell culture 
membrane that separates NECs from mono-DCs impairs antigen capture by the DCs. 
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This could provide a possible explanation for the limited influenza-induced changes in 
maturation markers CD11c and CD86 and the lack of influenza-induced changes in 
CD40, CD209, and CD11b that we observed during influenza infection in both 
nonsmoker and smoker co-cultures despite drastic differences in antiviral responses. In 
addition, our model compared the ability of NECs from smokers vs. non-smokers to 
communicate with mono-DCs . It has been shown that peripheral blood mononuclear 
cells (PBMC) from smokers have an overall suppressed type I IFN response to poly I:C, a 
mimetic of double stranded viral RNA, (148). Thus, generating mono-DCs using 
monocytes from smokers in this co-culture model could provide information on how 
signals emanating from influenza-infected NEC result in different activation and 
maturation of mono-DCs obtained from smokers. 
Nasal epithelial cells are a useful model for studying innate immune responses of 
the airways. During a respiratory viral infection, secretion of antiviral and immune 
activating mediators from the respiratory epithelium engages accessory cells (like NK 
cells, DCs, monocytes, etc) to induce an innate immune response (149). Mucosal 
epithelial cells in the nasopharynx act as a first line of defense where they must 
differentiate between harmless and disease causing pathogens such as influenza and will 
therefore set the stage for a respiratory immune response (149). Compared to bronchial 
cells of the lower airways, NEC have similar profiles of baseline as well as cytokine-
stimulated inflammatory mediators (150). Recent genome-wide expression analyses have 
shown that gene expression patterns of epithelial cells from the nose and bronchial region 
overlap significantly at baseline and that similar smoking –induced changes are reflected 
in both cell types (151). In our own publications, we have shown that nasal and bronchial 
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epithelial cells have comparable influenza-induced IFNα, IFNβ, and IFNΩ expression 
albeit with differing magnitudes of response (130), further supporting the hypothesis that 
the smoking-induced changes we observed in NEC are likely to be present in the lower 
airways as well, at least qualitatively  
As we discussed previously (53), NEC from smokers and non-smokers when 
differentiated in vitro appear to resemble their in vivo counterparts, including the 
persistence of high MUC5B expression overtime (53), and smoking-induced changes in 
phenotypes of NEC were associated with epigenetic changes in these cells. Specifically, 
we have previously shown that suppression of influenza-induced IRF7 expression in 
NEC from smokers was associated with enhanced DNA methylation of the IRF7 gene in 
NEC (53) which also correlates with our findings here. In addition to IRF7, DNA 
methylation patterns of other genes are altered in airway epithelial cells from smokers, 
and will be further discussed in Chapter 5. Determining the effects of these epigenetic 
changes may elucidate mechanisms of immune suppression in smokers.  
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Table 1. Baseline Antiviral and Chemokine mRNA Expression in Co-Culture NECs is 
Similar Between Nonsmokers and Smokers.  
NECs from nonsmoker and smoker NEC/mono-DC co-cultures were harvested 24 h post 
influenza infection. Baseline NEC mRNA expression levels for antiviral mediators and 
chemokines are depicted. Data are mean ± SEM and analyzed using a nonparametric 
Mann-Whitney U Test.  
 
 Nonsmoker  
n =6 
Smoker  
n=6 
p  
IRF7  19.0 ±  6.64  21.2 ± 8.79  0.937  
TLR3  0.640 ± 0.293  0.138 ± 0.009  0.093  
RIG-I  0.845 ± 0.251  1.39 ± 0.439  0.240  
    
 Nonsmoker 
n=5 
Smoker 
n=5 
p 
IP-10  1.40 ± 0.669 1.70 ± 0.761 0.841 
RANTES  0.932 ± 0.393  0.576 ± 0.236  0.691  
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Figure 4. Development of NEC/Mono-DC Co-Culture Model. 
A) NEC were obtained from healthy nonsmoker and smoker human volunteers and plated 
on cell culture inserts. After cells become confluent, an air liquid interface was 
established and retinol was added to promote mucociliary differentiation. NEC were fully 
differentiated after 3-4 weeks. B) Monocytes were harvested from peripheral blood 
mononuclear cells (PBMC) from normal, non-asthmatic, nonsmokers. Monocytes were 
treated with 30 ng/ml GM-CSF and 30 ng/ml IL-4 for 5-7 days. Mono-DCs were 
harvested and applied to the basolateral side of differentiated NEC grown on membrane 
support for 2 hours. Non-adherent mono-DCs were removed, and the NEC/mono-DC co-
cultures were placed in basolateral media. 
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Figure 5. Visualization of the NEC/Mono-DC Co-Culture Model. 
Co-culture membranes were fixed in ice cold methanol for 20 minutes and stored in 70% 
ethanol until analysis. Antibodies to CD11c and acetylated α-tubulin were used to 
identify mono-DCs and cilia of NEC, respectively. Following incubation with secondary 
Alexa 596 (NEC, red) and Alexa 488 (mono-DCs, green) conjugated antibodies samples 
were visualized using confocal microscopy. Z-stack analyses were used to visualize 
cross-sections of the co-culture system. 
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Figure 6. Mono-DCs Co-Cultured With Either Nonsmoker or Smoker NEC Have Similar 
Influenza-Induced Changes in DC Maturation Markers. 
Mono-DCs were isolated from peripheral blood monocytes and applied to the basolateral 
side of differentiated NEC from either nonsmoker or smoker for 2 h followed by 
infection with influenza from the apical compartment. 24 h post infection, mono-DCs 
were harvested from co-cultures by mechanical disruption and stained for DC markers 
using flow cytometry. A) CD45+ leukocytes are identified in the P1 gate. Representative 
histogram plots showing expression of DC markers B) CD11b C) CD40, D) CD209, E) 
CD11c, and F) CD86 and DC marker response to influenza (fold induction) G) CD11b, 
H) CD40, I) CD209, J) CD11c, K) CD86 are shown. CD11b, CD40, CD209, CD11c 
nonsmoker n=6, smoker CD86 nonsmoker n=7, smoker n=6. Data are expressed as fold 
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induction over non-infected control and as mean ± SEM. # p<0.05 vs non-infected 
control. 
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Figure 7. NEC From Smokers Have Suppressed Influenza-Induced Antiviral Responses. 
NEC total RNA and whole cell lysates from nonsmoker and smoker NEC/mono-DC co-
cultures were collected 24 h post influenza infection. A) Real time qRT-PCR was 
performed for IRF7. B) NEC whole cell lysates were analyzed by western blotting for 
IRF7 and then stripped and probed for βactin. Real time qRT-PCR was performed for C) 
TLR3 and D) RIG-I. mRNA expression of targets was normalized to β-actin, quantified 
using the ΔΔ Ct method, and expressed as fold induction over non-infected control. 
mRNA data are expressed as mean ± SEM: nonsmoker n=6, smoker n=6. For western 
blots, representative immunoblots are shown: nonsmoker n=2, smoker n=2. ##p<0.01, 
###p< 0.001 vs non-infected control, **p<0.01, ***p<0.001 nonsmoker vs smoker. 
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Figure 8. Mono-DCs Co-Cultured With Smoker NEC Have Suppressed Influenza-
Induced Antiviral Responses. 
RNA isolated from co-culture mono-DCs was collected 24 h post influenza infection. 
Real time qRT-PCR was performed for A) IRF7, B) RIG-I, and C) TLR3. mRNA 
expression of targets was normalized to β-actin, quantified using the ΔΔ Ct method, and 
expressed as fold induction over non-infected control. Data are expressed as mean ± 
SEM. Nonsmoker n=5, smoker n=5. #p<0.05 vs non-infected control, *p<0.05 
nonsmoker vs smoker.  
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Figure 9. NEC From Smokers As Well As Mono-DCs Derived From Co-Cultures Using 
Smoker NEC Have Suppressed Influenza-Induced Th1 Responses. 
NEC and mono-DC total RNA from nonsmoker and smoker NEC/mono-DC co-cultures 
was collected 24 h post influenza infection. Real time qRT-PCR was performed for IP-10 
in A) NEC and B) mono-DCs. Real time qRT-PCR was also performed for RANTES in 
C) NEC and D) mono-DCs. mRNA expression of targets was normalized to β-actin, 
quantified using the ΔΔCt method, and expressed as fold induction over non-infected 
control. Data are expressed as mean ± SEM. Nonsmoker n=5, smoker n=5. #p<0.05, 
##p<0.01, ###p<0.001 vs non-infected control, *p<0.05, ***p<0.001 nonsmoker vs 
smoker.  
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Figure 10. NEC/Mono-DC Co-Culture Apical Washes and Basolateral Supernatants 
Using NEC From Smokers Have Suppressed Influenza-Induced Th1 Chemokines. 
NEC/mono-DC co-cultures using NECs from nonsmokers and smokers were harvested 
24 h post influenza infection. IP-10 protein levels in A) apical washes (nonsmoker n=8, 
smoker n=7) and B) basolateral supernatants (nonsmoker n=5, smoker =7) and RANTES 
protein levels in C) apical washes (nonsmoker n=8, smoker n=7) and D) basolateral 
supernatants (nonsmoker n=9, smoker n=7) were measured by ELISA. #p<0.05, 
##p<0.01, ###p<0.001 vs non-infected control, *p<0.05, ***p<0.001 nonsmoker vs 
smoker.  
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Figure 11. NEC/Mono-DC Co-Culture Supernatants Using NEC from Smokers Have 
Increased Influenza Induced Levels of the Th2 Chemokine TSLP. 
Basolateral supernatants from NEC/mono-DC co-cultures were collected 24 h post 
influenza infection and were analyzed via ELISA for A) TSLP nonsmoker n=9, smoker 
n=8, and B) TARC nonsmoker n=10, smoker n=8. Data are expressed as fold induction 
over non-infected control and as mean ± SEM.  #p<0.05 vs non-infected control, *p<0.05 
nonsmoker vs smoker. C) Basolateral supernatants from NEC cultured alone were 
collected 24 h post influenza infection and were analyzed for TARC levels via ELISA. 
Data are expressed as mean ± SEM. Nonsmoker n=7, Smoker n=5. #p<0.05 vs non-
infected control.
  
 
 
CHAPTER 3 
NASAL NATURAL KILLER CELL FUNCTION IS SUPPRESSED IN SMOKERS 
AFTER LIVE ATTENUATED INFLUENZA VIRUS  
Abstract 
Background: Modified function of immune cells in nasal secretions may play a role in the 
enhanced susceptibility to respiratory viruses that is seen in smokers.  Innate immune 
cells in nasal secretions have largely been characterized by cellular differentials using 
morphologic criteria alone, which have successfully indentified neutrophils as a 
significant cell population within nasal lavage fluid (NLF) cells. However, flow 
cytometry may be a superior method to fully characterize NLF immune cells. We 
therefore characterized immune cells in NLF by flow cytometry, determined the effects 
of live attenuated influenza virus (LAIV) on immune NLF cell function, and compared 
responses in samples obtained from smokers and nonsmokers.  
Methods: In a prospective observational study, we characterized immune cells in NLF of 
nonsmokers at baseline using flow cytometry and immunohistochemistry. Nonsmokers 
and smokers were inoculated with LAIV on day 0 and serial nasal lavages were collected 
on days 1-4 and day 9 post-LAIV. LAIV induced changes of NLF cells were 
characterized using flow cytometry. Cell-free NLF was analyzed for immune mediators 
by ELISA and bioassay.   
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Results: CD45(+)CD56(-)CD16(+) neutrophils and CD45(+)CD56(+) natural killer (NK) 
cells comprised median 4.62% (range 0.33-14.52) and 23.27% (18.29-33.97), 
respectively, of non-squamous NLF cells in nonsmokers at baseline. LAIV did not induce 
changes in total NK cell or neutrophil percentages in either nonsmokers or smokers. 
However, following LAIV inoculation, cytotoxic CD16(+) NK cell percentages and 
granzyme B levels increased in nonsmokers, and these effects were suppressed in 
smokers. Smokers also showed decreased levels of NK cell chemokine thymus and 
activation-regulated chemokine (TARC) in NLF. LAIV induced expression of activating 
receptor NKG2D and chemokine receptor CXCR3 in peripheral blood NK cells from 
both nonsmoker and smoker in vitro but did not induce changes in cytotoxic CD16(+) 
NK cells or granzyme B activity in either group.   
Conclusions: These data are the first to identify NK cells as a major immune cell type in 
the NLF cell population and demonstrate that mucosal NK cell cytotoxic function is 
suppressed in smokers following LAIV. Altered NK cell function in smokers suggests a 
potential mechanism that may mediate a heightened susceptibility to respiratory viruses. 
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Introduction 
The nasal mucosa is the first site within the respiratory system to be exposed to 
pollutants and inhaled viral pathogens, including influenza. Therefore, nasal immune 
cells are likely to play important roles in early innate immune responses to these 
environmental stimuli. While macrophages and DCs have been identified in the nasal 
submucosa (152), and neutrophils have been identified in the nasal cavity (3), the overall 
immune cell populations within the nasal cavity have not been fully characterized. To 
phenotype nasal lavage fluid (NLF) cells, many researchers use cell differential analysis 
of cytocentrifuge slides stained with hematoxylin and eosin (H&E). Granulocytes are the 
easiest leukocytes to identify with H&E staining due to their polymorphic nuclei and are 
distinguished based on cytoplasmic staining: neutrophils have pale cytoplasm, 
eosinophils have a red granular cytoplasm, and basophils have a purple granular 
cytoplasm (153). T or B lymphocytes are smaller cells with dark, dense nuclei and little 
cytoplasm (153). NK cells are larger lymphocytes with a pale cytoplasm and are difficult 
to distinguish due to a lack of specific cellular morphology. In fact, NK cells appear 
similar to macrophages or monocytes after H&E staining (153). As a result, neutrophils, 
basophils, and eosinophils, but not NK cells, have been identified in NLF using cell 
differentials with H&E staining (154-156).  
As an alternative to H&E staining, flow cytometry can be used to positively 
identify leukocytes in NLF. Flow cytometry has previously identified neutrophils in the 
NLF using CD16 expression (4; 157) but expression of CD56, the classical NK cell 
marker, has not been used to positively identify NK cells in NLF. However, flow 
cytometric analysis has positively identified CD56(+) NK cells as well as CD3(+) T 
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lymphocytes and HLA-DR(+) alveolar macrophages in the bronchoalveolar lavage of 
lung transplant recipients (158). Thus, NK cells have been identified in the airways of 
humans, (5) but whether NK cells are present in the nasal cavity and how they could 
function as a guard against inhaled pollutants or pathogens is not known.  
Influenza infection induces the recruitment of immune cells into the lung, 
including NK cells (5). NK cells perform essential functions such as killing virus infected 
epithelial cells and secreting cytokines to regulate innate and adaptive immune responses 
(159). CD16, an FC receptor that induces antibody-dependent cell mediated cytotoxicity 
(160), is classic marker identifying neutrophils (161) but is also expressed on cytotoxic 
NK cells (159). CD16(+) cytotoxic NK cells also have dim CD56 expression and release 
cytotoxic granules containing perforin and granzymes to induce apoptosis in influenza 
infected cells (162). In contrast, CD16(-) NK cells have bright CD56 expression and are 
chiefly considered “cytokine secreting” NK cells as they secrete IFNγ that matures 
dendritic cells (DCs) (162).  
NK cell activation during influenza infection is regulated by the 
microenvironment. In particular, the respiratory mucosa secretes RANTES and IP-10(19; 
21) which bind to chemokine receptors CCR5 and CXCR3, respectively, on NK cells. In 
addition to IP-10 and RANTES, activated NK cells can secrete and respond to 
chemokines such as TARC and monocyte derived chemokine (MDC) (21). While 
multiple cell types produce these mediators, through secretion of these cytokines, NK 
cells engage in a positive feedback loop that enhances the NK cell pool (163). NK cells 
can also be activated by receptor mediated interactions. NK cells express many activating 
receptors, including NKG2D, which recognizes ligands induced during cellular stress. As 
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such, binding of ligands to the NKG2D receptor on NK cells enhances NK cell cytokine 
production as well as cytotoxic activity (19). In this manner, influenza infection in the 
respiratory tract may activate NK cells either through modification of activating surface 
and chemokine receptors or enrichment of the NK cell cytokine microenvironment. 
However, the role of NK cells in antiviral responses to influenza infection within the 
nasal passages has yet to be determined.  
Airborne pollutants, such as CS, have been shown to increase susceptibility to 
respiratory viral infections, including influenza 
[18-20]
. We have recently demonstrated that 
smokers’ nasal epithelial cells have modified responses to influenza infections both in 
vivo (3) and ex vivo (53) resulting in increased markers of influenza infection. Because 
NK cells can control and regulate viral infections via killing of infected respiratory 
epithelial cells, altered NK cell functions in smokers could contribute to enhanced 
influenza infections. Although smoking has been shown to suppress peripheral NK cell 
activity ex vivo (75-77; 79; 164), the effects of smoking on respiratory NK cell functions 
are unknown. 
[24]
 
Our goals were to 1) phenotype immune cells in the nasal passages using flow 
cytometry, 2) determine the presence and function of these cells in the context of a viral 
infection, and 3) assess the effects of cigarette smoke exposure on nasal immune cell 
function. Nonsmokers and smokers were inoculated with the live attenuated influenza 
virus (LAIV) vaccine, similar to our previous study (3). Serial nasal lavages were used to 
compare immune cell, and specifically NK cell, function in the nasal cavity of smokers 
and nonsmokers. Our results show that NK cells are present in the NLF, NK cells in the 
NLF change after inoculation with LAIV, and NK cell responses are modified in smokers 
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following LAIV.
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Methods 
Effect of LAIV on Nasal Immune Responses: Study Design  
This was a prospective longitudinal study comparing responses to LAIV between 
cohorts of healthy young adult smokers and nonsmokers. The study design was as 
described before (3). Baseline measurements were done at a screening visit and Day 0. 
On Day 0 subjects received a standard nasal inoculum of the 2008-2009 formulation of 
LAIV (FluMist®, MedImmune, Gaithersburg, MD; administered by study nurse 
according to manufacturer's instructions) in both nostrils, then returned on Days 1, 2, 3, 4, 
and 9 post-LAIV for serial nasal lavages. Subject exposure history questionnaires and 
urine cotinine levels were used to estimate cigarette smoke exposure.  
Study Subjects 
Subjects were identified as described before (3) and included healthy young 
adults between 18-35 years old in two groups: Group 1 = nonsmokers not regularly 
exposed to secondhand smoke and Group 2 = self-described active cigarette smokers. 
Informed consent was obtained from all subjects and the protocol was approved by the 
UNC Biomedical Institutional Review Board. Exclusion criteria were as described before 
(3). Table 2 details demographic and smoke exposure characteristics of the subjects 
completing the study. Nonsmokers and smokers did not differ significantly for age, BMI, 
or gender. One of 14 enrolled nonsmoker subjects and 5 of 20 enrolled smoker subjects 
dropped out before completion of the study. Two smoker nasal lavage fluid sample sets 
were compromised by freezer malfunction and therefore were not included in the 
analysis. Self described smokers had significantly higher secondhand smoke exposure 
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and urine cotinine values compared to nonsmokers. No serious adverse events occurred 
among subjects completing the protocol. Informed consent was obtained from all subjects 
and the protocol was approved by the UNC Biomedical Institutional Review Board.  
Nasal Lavage 
Nasal lavage was performed using a method we have previously described (3; 
165).  In brief, 4 ml of saline was sprayed into each nostril in 100 ul repetitive sprays 
followed by periodic forceful expulsion of fluid into a collection cup. Fluid from both 
nostrils was pooled. The NLF was filtered using 40 μm cell strainer (BDBiosciences, San 
Jose, CA), and the NLF filtrate was pelleted by centrifugation. Cell-free NLF was stored 
in aliquots at -80
o
C until used in mediator assays. Contents of the cell strainer were 
treated with 5% dithiothreitol (DTT) solution (Sputolysin®, EMD Chemicals, 
Gibbstown, NJ). Filtered cells were combined with DTT treated cells to comprise the 
total NLF cell pellet. Cytocentrifuge slides were stained for differential cell counts and 
immunohistochemistry as described below The NLF cell pellet was processed for flow 
cytometry as described below to identify and quantify immune cells.   
NLF Cell Differentials and Immunohistochemistry 
Cytocentrifuge slides were prepared, fixed, and stained using a modified Wright 
stain for differential cell counts. For immunohistochemistry, cytocentrifuge slides were 
fixed with ice-cold methanol, washed with TBS and blocked with Powerblock (Biogenex, 
San Ramon, CA) for 1 hr at room temperature. Cells were then incubated with the 
following primary antibodies: mouse anti-human CD56 antibody (MAB24081 RnD, 
Minneapolis, MN) or mouse anti-human perforin (BD Biosciences) overnight at 4°C. The 
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slides were washed with TBS. Following incubation with an HRP (horse radish 
peroxidase)-conjugated secondary antibody, samples were washed with TBS and 
evaluated under light microscopy. Nonspecific staining was assessed by omitting the 
target-specific primary antibody.  
Ex vivo NLF Cell Flow cytometry 
The NLF cell pellet was suspended in flow cytometry buffer (PBS, 0.09% sodium 
azide, 1% heat inactivated FBS) and stained with antibodies to CD16 FITC (Beckman 
Coulter, Brea, CA), CD14 Pacific Blue (Biolegend, San Diego, CA) CD56 PE, CD4 Pe-
Cy5, CD3 PerCP, CD45 APC-Cy7 (BD Biosciences) for 20 minutes at room temperature 
in the dark. Cells were washed with flow cytometry buffer, resuspended in 0.5% 
paraformaldehyde, and stored at 4°C in the dark. Samples were acquired within 24 hrs on 
a BDLSRII flow cytometer (BD Biosciences). Isotype-matched single color controls 
were used to control for nonspecific staining and to set analysis gates. 
NLF Mediator and Urine Cotinine Assays. 
NLF granzyme B activity was measured using a SensiZyme Granzyme B Activity 
kit (Sigma, St. Louis, MO). RANTES was quantified using commercially available 
ELISA (R&D, Minneapolis, MN) according to manufacturer's instructions. MDC, MCP-
1, and TARC were quantified using a 9 assay multiplex ELISA platform (Meso Scale 
Discovery, Gaithersburg, MD). Urine cotinine was measured by ELISA (Bio-Quant, Inc., 
San Diego, CA) and expressed as a ratio to creatinine, measured by a colorimetric assay 
(Oxford Biomedical Research, Rochester Hills, MI). 
In vitro NK Cell Stimulation Assays 
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Peripheral blood NK cells were isolated from PBMC from nonsmokers and 
smokers at baseline and stimulated in vitro with the 2008-2009 strain of LAIV. PBMC 
were isolated from nonsmokers and smokers using Lymphoprep™ (Axis-Shield, Oslo, 
Norway). NK cells were isolated from PBMC using negative selection for CD56 
(Dynabeads® Untouched™ Human NK cells isolation kit, Invitrogen, Carlsbad, CA) 
according to manufacturer’s instructions. 1x105 NK cells were stimulated with 0.1 ul 
(2.56 HAU) LAIV (see below) in 100 ul of RPMI media containing 10% FBS, l-
glutamine (Invitrogen), and penicillin:streptomycin (Invitrogen) for 24 h at 32°C in 5% 
CO2. NK cells were centrifuged at 500 g for 5 min and processed for flow cytometry as 
described below. Cell free supernatant was aliquoted and stored at -80°C for assessment 
of granzyme B activity as described below.  
LAIV Propagation in MDCK Cells in vitro 
The 2008-2009 LAIV strain was propagated in Madin-Darby Canine Kidney 
(MDCK) epithelial cells in vitro. 0.05 MOI LAIV stimulated 90% confluent MDCK cells 
in serum free DMEM media supplemented with pen-strep, l-glutamine and 0.2% trypsin 
without EDTA (all Invitrogen) and incubated for 48 h at 32°C in 5% CO2. The cell 
supernatant was gently aspirated and combined with 10% fetal bovine serum (Invitrogen) 
to inactivate trypsin. Cells and debris were pelleted by centrifugation at 500 g for 10 
minutes. Cell free supernatant was concentrated by centrifugation with an Amicon Ultra-
15 Centrifugal Unit (Millipore, Billerica, MA) using a 100,000 molecular weight cutoff. 
Smaller proteins (cytokines) fall through the filter whereas larger viruses (LAIV) are 
collected. To generate a vehicle control, MDCK cells were mock-infected with media and 
the supernatant was processed in the same fashion. Concentrated LAIV was aliquoted 
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and stored at -80°C until use. LAIV was titered using a hemagglutination assay as 
described before (166). The titer for the propagated virus was 25.6 HAU (hemagglutinin 
units)/ul, which was 8x higher than the original 2008-2009 LAIV strain (data not shown). 
MDCK-propagated LAIV was used in all in vitro assays.  
Peripheral NK Cell Flow Cytometry 
NK cells were washed and resuspended in flow cytometry buffer and stained with 
antibodies to CD16 FITC (Beckman Coulter), CD56 PE, CD3 APC-Cy7 (BD 
Biosciences), CXCR3 and NKG2D (Biolegend) for 20 minutes at room temperature. 
Cells were washed with flow cytometry buffer, resuspended in 0.5% paraformaldehyde, 
and stored at 4 C in the dark. Samples were acquired within 24 hrs on a BDLSRII flow 
cytometer (BD Biosciences). 
Peripheral NK Cell Granzyme B Activity 
Granzyme B activity from the in vitro LAIV NK cell stimulation was quantified 
as described before (167). Briefly, NK cell supernatants were combined 1:1 with 50 mM 
HEPES pH 7.5, 0.1% CHAPS, 10% sucrose, (all Sigma) and 400 uM colorimetric 
granzyme B substrate I (EMD4Biosciences, Merck, Darmstadt, Germany). Supernatants 
were incubated at 37°C in 5% CO2 for 24 h. Absorbance was read using a plate reader at 
405 nm wavelength. A standard curve of granzyme B (Sigma) with 1:1 serial dilutions 
was used to calculate specific activity. 
Statistical Analysis 
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Baseline differences between NLF cell populations were determined using a 
Mann-Whitney U test. The effects of smoking status on NLF responses to LAIV were 
analyzed using a Kruskal-Wallis One-way ANOVA followed by Bonferroni’s posttest to 
determine differences on individual days. An area under the curve (AUC) analysis 
followed by a Kruskal-Wallis One-way ANOVA was used as previously described (3) to 
determine the effects of smoking status on total immune NLF responses to LAIV. Within 
nonsmoker and smoker groups, Wilcoxon matched pairs tests were used to determine the 
effects of LAIV on peripheral NK cells in vitro. Data were shown as mean ± SEM or 
median (interquartile range).  
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Results 
Characterizing Immune Cells in NLF In Nonsmokers At Baseline 
A representative cellular differential of NLF cells was pictured in Figure 12. 
Squamous cells (black arrows) in the nasal lavage comprised 52.0% (37.3-62.5) of total 
NLF cells in nonsmokers at baseline. Neutrophils (dashed arrows) could also be 
identified by morphology in the nasal lavage and comprise 7.7% (2.1-16.5) of non-
squamous NLF cells. We used flow cytometry to positively identify other non-squamous 
NLF cells. As shown in Figure 13, forward scatter (FSC) and side scatter (SSC) settings 
eliminated squamous epithelial cells from the view. Negative expression of CD45, a 
marker that stains only leukocytes, was used to discriminate between NLF non-squamous 
epithelial cells and NLF leukocytes of similar size. Figure 13 showed further analysis of 
CD45(+) NLF cells stained for surface marker expression of CD3 (T lymphocytes), CD4 
(T helper lymphocyte) CD14 (monocytes), CD16 (neutrophils), and CD56 (NK cells). 
These data showed that of the markers tested, only subpopulations positive for CD16 and 
CD56 were identified in CD45
+
 NLF cells.  
To further characterize the immune phenotype of NLF cells, we focused our 
analysis on CD16 and CD56. In Figure 14A, a representative flow cytometric dot plot 
showed CD16 and CD56 co-expression on CD45(+) cells. Distinct CD56(+) NK cell 
(upper left quadrant) and CD56(-)CD16(+) neutrophil (lower right quadrant) populations 
were depicted. Also, CD16(-) NK cells appeared to have “brighter” CD56 expression 
compared to their CD56(+)CD16(+) NK cell counterparts. Figure 14B indicated that NK 
cells comprised a greater percentage [23.3% (18.3-34.0)] compared to neutrophils [4.6% 
(0.3-14.5)] of non-squamous NLF cells (p<0.01). Percentages of cytokine-secreting 
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CD16(-) NK cells [13.0% (10.4-20.3)] were greater than percentages of cytotoxic 
CD16(+) NK cells [8.8% (3.6-12.7)] in nonsmokers at baseline as shown in Figure 14C 
(p<0.05). None of the CD45(+) leukocytes in the nasal lavage were CD3(+), indicating 
that the CD56(+) cells were not natural killer T (NKT) cells.  
We used immunohistochemistry to confirm the presence of NK cells in the NLF. 
Positive immunohistochemical staining for CD56 identified NK cells in Figure 15A. 
Cytotoxic NK cells were identified by immunohistochemical staining for perforin, a 
cytotoxic granule expressed in cytotoxic T lymphocytes and NK cells, as shown in Figure 
15B.  
Comparison of Nonsmokers vs. Smokers After LAIV 
Smoker and nonsmoker groups did not differ by age, BMI, or gender (Table 2). 
As expected, smokers had significantly greater average urine cotinine levels than 
nonsmokers, indicating that the smokers continued to actively smoke during the study 
period.  
Using flow cytometry, percentages of NK cells and neutrophils were quantified in 
the non- squamous NLF cell population of nonsmokers and smokers before (Day 0) and 
after inoculation with LAIV (Days 1-4, 9). See schematic in Figure 16. There were no 
statistically significant differences in neutrophil percentages associated with either LAIV 
or smoking status (see Figure 17A), which confirms our previous observations (3). Total 
NK cell percentages were also similar between groups and unchanged after LAIV (Figure 
17B). To further characterize NK phenotypes after LAIV, proportions of cytotoxic NK 
cells within the total NK cell population were determined by assessing CD16(+) 
expression on NK cells using flow cytometry and cytotoxic NK cell activity was 
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determined by measuring granzyme B bioactivity in the NLF. CD16(+) NK cells 
increased by day 2 after LAIV in nonsmokers, but this increase was significantly blunted 
in smokers (Fig. 18A). Similarly, the rise in granzyme B seen in nonsmokers by day 3 
was significantly suppressed in smokers (Figure 18B); as well as an overall suppression 
of granzyme B response post LAIV in smokers, albeit not statistically significant 
(p=0.09, Table 3).  
Chemokines known to enhance NK cell function were quantified in the NLF. 
RANTES and MCP-1 levels were similar in both nonsmokers and smokers following 
LAIV inoculation (Figures 19A and 19B). MDC (Figure 19C) appeared to be suppressed 
in smoker NLF at baseline, although this effect was not statistically significant. TARC 
levels were suppressed in smoker NLF following LAIV both at Day 2 (Figures 19D) and 
overall following LAIV (Table 3, AUC analysis). Overall AUC analysis determined 
RANTES, MCP-1, and MDC levels were not affected by smoking status following LAIV 
(data not shown).  
To determine whether the effects of cigarette smoke exposure on NK cell function 
are evident systemically, peripheral blood NK cells were isolated from nonsmokers and 
smokers and stimulated ex vivo with LAIV.  Percentages of peripheral cytotoxic CD16(+) 
NK cells were not altered by ex vivo stimulation with LAIV in either nonsmokers or 
smokers (Figure 20A). Interestingly, peripheral blood cytotoxic CD16(+) NK cells 
composed a larger proportion of total NK cells [84.2% (79.3-90.4)] (Figure 20A) versus 
mucosal NK cell populations [28.3% (22.2-46.2)] in nonsmokers at baseline (Figure 18A) 
(p<0.0001). LAIV did not induce granzyme B secretion in peripheral NK cells from 
smokers or nonsmokers (Figure 20B). To determine if LAIV stimulation ex vivo can alter 
69 
expression of peripheral NK cell activating and chemokine receptors (NKG2D and 
CXCR3), we assessed receptor expression by flow cytometry. LAIV increased NKG2D 
(Figure 20C) and CXCR3 (Figure 20D) expression on peripheral NK cells from both 
nonsmokers and smokers. However, there were no differences in peripheral NK cell 
receptor expression between smokers and nonsmokers.
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Discussion 
Characterizing innate immune cells within the nasal passages is an important step 
in understanding how pre-existing conditions, such as smoking, affect anti-influenza 
responses in the respiratory epithelium. Using a model of in vivo human influenza 
infection (3) and ex vivo flow cytometric methodology, we demonstrated that 1) NK cells 
are present in nasal secretions and constitute a significant portion of NLF immune cells, 
2) the “normal” nasal NK cell response to LAIV involves an increase in activated 
cytotoxic NK cells, and 3) these LAIV-induced cytotoxic NK cell responses are 
suppressed in smokers. 
The identification of NK cells as a prominent immune cell type in NLF is, to our 
knowledge, a novel finding and suggests that the study of innate immune responses in the 
upper airways should take NK cells into account. The use of cell differentials alone to 
phenotype NLF cells has likely overlooked NK cells (154-156). As shown in Figure 4, 
NK cells have non-descript morphologies and could be mistaken for NLF monocytes, 
macrophages or even basal epithelial cells. Using flow cytometry, other researchers have 
identified CD16(+) NLF cells. However, these CD16(+) cells were either classified as 
neutrophils (157) or the analysis gate was based on the relative size of a lymphocyte 
population (4), thus likely excluding NK cells. In our study, activated NK cells in NLF 
appeared to be of similar size and granularity as neutrophils as evidenced by the flow 
cytometric CD56 staining and SSC properties (see Figure 13). This is not surprising as 
both NK cells and neutrophils contain cytotoxic granules that should influence their SSC 
fluorescence. Figure 4 shows that NK cells positively identified in the NLF using 
immunohistochemistry are relatively large cells compared to T lymphocytes (153) and 
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have significantly greater cytoplasm/nucleus ratio. In addition, CD56 is essential to 
positively identify NK cells. A previous report did not observe any CD56(+) NK cells in 
NLF (168), but these studies used a significantly different study population (allergic 
rhinitics) and were focused on IL-4 producing lymphocytes, not NK cells, within the 
NLF (168). In addition, they, as well as others (4; 155-157), perform nasal lavages by 
administering a single bolus dose of saline which is held in the nasal cavity and then 
passively expelled (168). This is in contrast to our method, which uses repetitive spraying 
of smaller volumes of saline followed by forceful expulsion and collection. We speculate 
that compared to the bolus method of NLF collection, our method may be more 
mechanically disruptive to the nasal mucosa and thus produces higher numbers of NLF 
immune cells. However, in the NLF analyzed here, neutrophils, characterized both by 
cellular differential and flow cytometry analysis, were at levels similar to what has been 
described in bolus nasal lavages of normal human subjects at baseline by cell differential 
analysis (169).  
Our data also show that NLF NK cells are activated during an influenza infection 
in healthy nonsmokers. Multiple signals contribute to NK cell activation including direct 
engagement of NK cell activating receptors by influenza virus (170), autocrine 
stimulation by activated NK cell derived chemokines (21; 171), and paracrine stimulation 
by other immune cells like DCs (172; 173). Therefore, NK cell activation is in part 
dependent on communication with other cell types. We have shown here that LAIV 
increases cytotoxic CD16(+) NK cell percentages and granzyme B activity in the NLF of 
nonsmokers, but did not observe similar increases in peripheral NK cells alone. This 
suggests that in the setting of infection, chemokines and mediators released by other cells 
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within the nasal mucosa assist in activating and maturing NK cells. We have previously 
shown that influenza-induced IP-10 levels are reduced in the nasal epithelium of smokers 
both in vivo (3) and ex vivo (174). IP-10 secreted from the nasal epithelium can induce 
chemotaxis and enhance cytotoxic activity in resting NK cells (21), suggesting that a 
decrease in IP-10 levels in the context of a viral infection may lead to the suppressed NK 
cell cytotoxic responses demonstrated here. Tobacco smoke-induced decreases in 
activating cytokines such as IP-10, MDC, and TARC could create a microenvironment 
unfavorable for NK cell maturation resulting in suppressed CD16(+) NK cell 
percentages, granzyme B activity, and suppression of IFNγ in the NLF, which we have 
shown previously (3). Interestingly, our ex vivo co-culture model of influenza infection 
introduced in the previous chapter demonstrated that smoker NEC had enhanced 
secretion of TARC, as opposed to suppressed secretion, following influenza, which is in 
contrast to the findings discussed in this chapter. Taken together these data suggest 1) not 
all conclusions drawn from different model systems are analogous and 2) TARC may 
have differential roles depending on the target cells involved (DCs vs. NK cells) during 
an influenza infection.  
Our data suggest that peripheral NK cell responses are not affected by smoking 
status. CD56
bright
 CD16(-) cytokine-secreting NK cells predominate in lymph nodes and 
mucosal tissues, whereas CD56
dim 
 CD16(+) cytotoxic NK cells are found in higher 
percentages in the peripheral blood (5). Because total NK cell percentages in NLF did not 
change following LAIV in either nonsmokers or smokers in our study, it is possible that 
the cytokine milieu within the nasal mucosa induced NK cell switching from a cytokine 
secreting to a cytotoxic phenotype (175). We did not observe this class switching in 
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peripheral NK cells inoculated with LAIV, which may be due to either differences in NK 
cell phenotypes or the lack of maturation cytokines from exogenous immune and 
respiratory cells present in the nasal mucosa. In addition, while stimulation with LAIV ex 
vivo did enhance activation markers NKG2D and CXCR3 on peripheral blood NK cells 
in both nonsmokers and smokers, LAIV did not induce granzyme B bioactivity in 
peripheral NK cells ex vivo in either group. This suggests that peripheral and mucosal NK 
cell phenotypes and responses are distinct and that NK cells require a combination of 
signals derived from direct infection and exposure to a maturation cytokine mixture to 
become fully activated and secrete cytotoxic granzymes.  
Smokers are prone to respiratory microbial and viral infections, including 
pneumococcal pneumonia, legionellosis, meningococcal disease, rhinovirus, and 
influenza virus (48). We have shown here that smokers have decreased NK cell activity 
in the nasal passage, and this lack of functional NK cells patrolling the upper airways 
may contribute to increased respiratory infections. Interestingly, decreased NK cell 
cytotoxicity may also play a role in tumorigenesis in the respiratory system (15). NK 
cells from smokers have decreased anti-tumor action ex vivo (176), and decreased 
peripheral lymphocyte cytotoxicity ex vivo is associated with increased cancer risk (177). 
Thus, enhancement of NK cell function against infected cells or tumors could be an 
important therapeutic strategy for both smokers and cancer patients. For cancer patients, 
several NK cell therapies are already in clinical trials (178). Adiponectin treatment of NK 
cells exposed to cigarette smoke ex vivo partially restores NK cell cytotoxicity, 
suggesting that adiponectin may be an intriguing candidate for NK cell enhancement 
(179). Thus, suppressed NK cell activity in the nasal secretions of smokers may 
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contribute to the suppressed anti-viral and anti-tumor function seen in the respiratory 
tracts of smokers.   
NK cells in the nasal secretions may play important roles in nasal immunity 
through control of respiratory viral infections both in normal individuals and those with 
underlying respiratory conditions. Viral infections and inflammation within the nasal 
passages could affect immune responses in the lower airways, especially in individuals 
with underlying lower airway disease such as chronic obstructive pulmonary disease 
(COPD) or asthma. COPD is also associated with nasal inflammation and blockage of the 
upper airways (180). In asthmatic individuals, treatment of rhinitis and sinusitis improves 
asthma disease symptoms (181), indicating that nasal inflammation can affect asthma 
symptoms. Infections with viruses such as human rhinovirus are a major cause of both 
COPD and asthma exacerbations and the majority of these infections originate in the nose 
(182). Thus, innate immune cells, particularly NK cells, could play important roles in 
controlling viral infections and inflammation within the nose and prevent worsening of 
preexisting respiratory conditions. In summary, we have demonstrated that NK cells are 
present in nasal secretions, and that NK cells could play an important role in nasal innate 
immunity to viruses, as well as in the suppressed immune responses to respiratory 
infection seen in smokers. Further study of this unique mucosal immune cell population 
will be beneficial in assessing the effects of both pollutants and pathogens on upper 
respiratory immune responses in individuals with potentially enhanced susceptibility due 
to pre-existing diseases.  
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Table 2.  Subject Characteristics and Tobacco Smoke Exposure 
 Nonsmoker Smoker 
 (N = 13) (N = 13) 
Age (yr) 25.3 ± 1.0 23.5 ± 1.2 
Gender 5M/8F 7M/6F 
BMI 25.1 ± 1.3 28.2 ± 2.3 
Daily exposure  
Cigarettes smoked
1
 NA 8.5 ± 1.6 
Urine cotinine
2
 0.0 ± 0.0 19.5 ± 7.1*** 
 
1
 Data shown as mean ± SEM for cigarettes smoked.  Data were averaged from each 
subject's self reported estimates for study days 0 through 9. 
2
 Data shown as mean ± SEM for mg cotinine (x 100) / mg creatinine.  Data were 
obtained using screen urine values.  
*** P < .0001 vs. nonsmoker 
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Table 3. Comparison of Total NLF Granzyme B and TARC Responses Post LAIV.   
 Control Smokers P (Kruskal-Wallis) 
 (N =13)  (N = 13)  
Granzyme B 225.0 111.5 0.09 
 (68.7-519.3)  (14.9-310.0)  
TARC 76.4 45.7* 0.03 
 (38.9-119.4)  (28.6-95.5)  
Data are shown as median (interquartile range). Area under NLF mediator quantity, Day 
1-9 after LAIV inoculation. Mediators with p >0.1 are shown. * P < 0.05 vs. Nonsmoker  
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Figure 1
 
Figure 12. Nasal Lavage Cells 
NLF cells from nonsmokers at baseline were stained with hematoxylin and eosin. 
Squamous epithelial cells (black arrows) and neutrophils (dashed arrows) can be 
positively identified. n=12. A representative image is shown.  Bar = 10 μm. 
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Figure 13. Nasal Lavage Immune Cell Flow Cytometry 
NLF cells were collected from nonsmokers at baseline and analyzed by flow cytometry 
for leukocyte markers. The majority of NLF squamous epithelial cells are gated out by 
FSC and SSC settings. CD45+ NLF leukocytes are identified in NLF cells. CD45+ NLF 
cells are negative for surface markers CD3 (T lymphocytes) CD4 (Helper T 
lymphocytes), and CD14 (monocytes). CD45+ NLF cells contained populations positive 
for CD16 (neutrophils, NK cells) and CD56 (NK cells). A representative image at 
baseline is shown. 
80 
Figure 3
B
0
10
20
30
**
NK Cells
P
e
rc
e
n
t 
o
f 
N
o
n
-S
q
u
a
m
o
u
s
N
L
F
 C
e
ll
s
 (
%
)
Neutrophils
A
0
5
10
15
20
*
CD16-
NK Cells
CD16+
NK Cells
P
e
rc
e
n
t 
o
f 
N
o
n
-S
q
u
a
m
o
u
s
N
L
F
 C
e
ll
s
 (
%
)
C
 
Figure 14. Characterization of NK Cells in the Nasal Lavage by Flow Cytometry. 
NK cells were identified in CD45+ NLF cell populations of nonsmokers at baseline. A)  
Representative flow cytometric plot depicting NK cells (CD56+) and neutrophils (CD56-
CD16+). B) Percentages of total NK cells are greater than neutrophils in non-squamous 
NLF cell populations. C) Percentages of CD16- NK cells are greater than percentages of 
CD16+ NK cells in non-squamous NLF cell populations. **p<0.01, * p<0.05. 
Nonsmoker n=11. 
81 
Figure 4
BA
 
Figure 15. Characterization of NK cells in the Nasal Lavage by Immunohistochemistry. 
NLF cells were characterized using immunohistochemistry.  A) NLF cells are stained 
with anti-CD56-HRP to identify NK cells and B) NLF cells are stained with anti-
perforin-HRP to identify cytotoxic NK cells. Bar = 10μm.  
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Figure 16. Schematic of LAIV Study Design. 
Nonsmokers and smokers were given a baseline nasal lavage followed by inoculation 
with LAIV on Day 0. Serial nasal lavages were obtained on Days 1-4 and again on Day 
9. Urine was collected throughout to study to measure cotinine, a metabolite of nicotine, 
as a marker of cigarette smoke exposure. 
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Figure 17. LAIV Does Not Significantly Affect Total NK Cell or Neutrophil Percentages 
in Nonsmokers or Smokers. 
Using flow cytometry we identified NK cells and neutrophils in nonsmoker and smoker 
non-squamous NLF cells after LAIV inoculation. Neither A) NK cell nor B) neutrophil 
percentages in total NLF cells change following LAIV in either group. Nonsmokers n=12 
(■, solid line), smokers n=9 (▲, dashed line). 
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Figure 18. Cytotoxic NK Cell Activity is Suppressed in Smokers Following LAIV. 
Cytotoxic NK cell percentages and activity were analyzed in NLF of nonsmokers and 
smokers after LAIV inoculation. A) CD16+ cytotoxic NK cell percentages of total NK 
cells were decreased in the NLF of smokers following LAIV. Kruskal-Wallis p=0.09, 
*p<0.05 nonsmoker vs smoker posttest. Nonsmokers n=12 (■, solid line), smokers n=9 
(▲, dashed line). B) Granzyme B activity was decreased in NLF of smokers following 
LAIV inoculation. Kruskal-Wallis p<0.01, *p<0.05 nonsmoker vs smoker posttest. 
Nonsmokers n=13 (■, solid line), smokers n=13 (▲, dashed line). 
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Figure 19. NK Cell Chemokine TARC is Decreased in Smoker NLF Following LAIV. 
Chemokines known to enhance NK cell function were quantified in the NLF of 
nonsmokers and smokers after LAIV inoculation. A) RANTES, B) MCP-1, and C) MDC 
were similar in nonsmokers and smoker NLF whereas D) TARC is suppressed in smoker 
NLF. Kruskal-Wallis p<0.05, ** p<0.01 nonsmoker vs smoker posttest. Nonsmokers 
n=13 (■, solid line), smokers n=13 (▲, dashed line). 
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Figure 20. Effect of LAIV On Peripheral NK Cell Activity 
Peripheral blood NK cells were isolated from nonsmokers and smokers and stimulated in 
vitro with LAIV. LAIV did not increase A) percent CD16+ cytotoxic NK cells or B) 
granzyme b activity in either nonsmokers or smokers. LAIV increased expression of C) 
NK cell activation receptor NKG2D and D) chemokine receptor CXCR3 in both 
nonsmokers and smokers. Nonsmokers n=6 (black bars), smokers n=6 (white bars). *** 
p<0.001 vs vehicle control. 
  
 
 
CHAPTER 4 
LIVE ATTEUNATED INFLUENZA VIRUS INDUCES MUCOSAL T CELL 
RESPONSES IN NONSMOKERS AND SMOKERS 
Abstract  
Rationale: Epidemiological evidence demonstrates smokers are more susceptible to 
respiratory infections, including influenza. Research suggests smoking suppresses innate 
immune responses to influenza infection, but the effect of smoking on mucosal T cell 
function remains poorly understood. To describe how CS affects influenza-induced T cell 
responses in the nasal mucosa, we inoculated nonsmokers and smokers with LAIV and 
assessed nasal mucosal T cell populations. Analyses were conducted using two separate 
study years. 
Methods: In the Year 2 study, mucosal T cell populations were harvested through nasal 
biopsy of the superficial inferior turbinate pre LAIV and on days 1 and 4 post LAIV from 
both nonsmoker and smoker subjects. Biopsies were digested with pronase and dispase to 
achieve a single cell suspension and analyzed using flow cytometry for CD45 leukocytes 
and were screened for cytotoxic lymphocytes (CD56), neutrophils and NK cells (CD16), 
macrophages and dendritic cells (CD1a and HLA-DR) CD16 (neutrophils, NK cells), 
CD1a and HLA-DR (macrophages, dendritic cells) and T cells (CD3,, CD4, CD8, and γδ 
TCR.) Results for specific γδ TCR chains were confirmed using stored nasal biopsy 
samples from Year 1 harvested on screen day and day 4 post LAIV. 
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Immunohistochemistry of nasal biopsy sections as well as qRT-PCR of nasal biopsies 
was used to determine the presence of γδ TCR chains.  
Results: CD45+ nasal biopsy cells were negative for CD16, CD56, CD1a, and HLA-DR 
but were positive for CD3. LAIV induced changes in percentages of CD3+ T cells and γδ 
T cells (CD3+CD4-CD8-γδTCR+) in the Year 2 study with no differences attributable to 
cigarette smoking. T helper cell (CD3+CD4+) and cytotoxic T cell (CD3+CD8+) 
populations were minimal in both nonsmokers and smokers by day 4 post LAIV. In the 
confirmatory analysis from Year 1, γδTCR+ cells were identified in nasal biopsies using 
immunohistochemistry on day 4 post LAIV. qRT-PCR analysis revealed that nasal 
biopsies, but not cultured NEC, were positive for Vδ1 and Vγ3 chains although LAIV did 
not upregulate TCR chain transcription.   
Conclusions: CS exposure did not have an obvious effect on mucosal T cell phenotypes. 
However, the infiltration of γδ T cells into the nasal mucosa post LAIV is a novel 
finding, and γδ T cells may play important roles in early adaptive immune responses to 
viruses in the respiratory mucosa.  
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Introduction 
Smokers have increased risk of respiratory infections such as influenza but the 
mechanisms mediating this susceptibility are unknown. During influenza infection, the 
activation of the adaptive immune system, including T and B lymphocytes, is necessary 
to both 1) clear the initial infection and 2) generate a memory response. Conventional T 
lymphocytes expressing the αβ TCR are divided into either CD4+ helper T cells that in 
the context of a viral infection generally enhance immune cell activity or CD8+ cytotoxic 
T cells that kill virally infected cells (30). γδ T lymphocytes or intraepithelial 
lymphocytes are at their highest concentration in epithelial tissues where they act as 
“transitional” T lymphocytes that behave similar to cytotoxic CD8 T cells but acquire 
their effector mechanisms quicker (30). (183). γδ T cells migrate to the airways during 
respiratory infections (37) including influenza (38; 39) and play an important role in 
innate and adaptive immune responses. Most of the knowledge of γδ T cell function 
originates from mouse models, and the exact TCR subsets important in respiratory 
responses to influenza viruses in humans are unknown (30). Classifying the subsets of γδ 
T cells in human airways is important as they can have differential cytolytic or cytokine 
secreting activity (30). In the human nasal epithelium γδ T cells positive for the Vδ1Vγ1 
chains have been identified in allergic rhinitics (184), and the Vδ1-3 and Vγ1-3 chains 
have been identified in normal individuals (185; 186). γδ T cells positive for the Vδ1 and 
Vγ1,2 chains (187) but not the Vδ2 chain have been also been identified in the bronchial 
epithelium of both smokers and nonsmokers. Therefore, γδ T cells are found in the 
respiratory epithelium of both nonsmokers and smokers. However, the role of γδ T cells 
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in the nasal epithelium during LAIV as well as the effects of CS exposure on γδ T cell 
activity remains unexplored. 
While there do not appear to be differences in influenza-specific antibody 
production in smokers (71-73), the effect of smoking status on the ability of T cells to 
mount proper mucosal immune responses is unknown. Because, both conventional αβ 
and nonconventional γδ T cell activity is influenced by DC activation, we hypothesize 
that smokers have decreased T cell activation following LAIV inoculation compared to 
nonsmokers. To determine if smoking affects mucosal T cell activation, we administered 
nonsmokers and smokers LAIV as described previously (3). Naïve T cell activation post 
LAIV in the nasal mucosa was quantified in nonsmoker and smoker subjects using flow 
cytometry and PCR.  
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Methods 
Study Design  
This was a prospective longitudinal study comparing responses to LAIV between 
cohorts of healthy young adult smokers and nonsmokers. This study compiles data from 
two separate study years in order to obtain enough material for analysis. In Year 1, 
subjects were inoculated with the 2008-2009 LAIV strain, and subject characteristics are 
described in Chapter 3 Table 2. These data were used for nasal biopsy mRNA and 
immunohistochemical analyses. In Year 2, subjects were inoculated with the 2009-2010 
LAIV strain and demographic and smoke exposure characteristics of the subjects 
completing the study are detailed in Table 4 of this chapter. These data were used for 
nasal biopsy flow cytometry analyses. The study design was as described before (3). 
Baseline measurements were done at a screening visit and Day 0. On Day 0 subjects 
received a standard nasal inoculum of LAIV (FluMist®, MedImmune, Gaithersburg, 
MD; administered by study nurse according to manufacturer's instructions) in both 
nostrils, then returned on day 4 post-LAIV for nasal biopsies in Year 1 and on days 1 and 
4 post-LAIV for nasal biopsies in Year 2. 
Study Subjects and Sample Estimate.   
Subjects were identified as described before (3) and included healthy young 
adults between 18-35 years old in two groups: Group 1 = nonsmokers not regularly 
exposed to secondhand smoke and Group 2 = self-described active cigarette smokers. 
Exclusion criteria were as described before (3). Subject exposure history questionnaires 
were used to estimate CS exposure. In both Year 1 and Year 2, nonsmokers and smokers 
did not differ significantly in age, BMI, or gender. In both Year 1 and Year 2, self 
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described smokers had significantly higher secondhand smoke exposure compared to 
nonsmokers. No serious adverse events occurred among subjects completing the protocol. 
Informed consent was obtained from all subjects and the protocol was approved by the 
UNC Biomedical Institutional Review Board. 
Nasal Biopsy 
Nasal biopsies were harvested from the inferior turbinates of both nostrils using a 
RhinoProbe cuvette and were placed in RPMI media. Biopsies were pelleted and treated 
with 15μg/ml dispase (Roche, Indianapolis, IN) and 5μg/ml pronase (Sigma, St. Louis, 
MO) for 30 minutes. FBS (Invitrogen) at a final concentration of 10% was added to the 
cell pellet and filtered with a 40 uM cell strainer (BD Falcon, San Jose, CA) to remove 
larger epithelial cells. The cell pellet was resuspended in 100 ul of flow cytometry buffer 
(PBS plus 1% heat inactivated FBS plus 0.09% sodium azide) and stained with surface 
markers CD45 APC-cy7, CD3 PerCP, CD4 APC, CD8 PE, CD56 PE, HLA-DR alexa 
700 (BDBiosciences), CD1a pacific blue (Biolegend, San Diego, CA), pan γδ TCR FITC 
,and CD16 FITC (Beckman Coulter, Brea, CA) for 20 minutes at room temperature. Cells 
were washed with flow buffer, fixed with 0.5% paraformaldehyde, and analyzed on a 
BDLSRII flow cytometer within 24 hours. T cells were identified by gating using 
forward scatter (FSC) and side scatter (SSC) settings and gating on cells staining positive 
for CD45 and CD3. 
Nasal Biopsy Immunohistochemistry 
Nasal biopsies were obtained on screen day and day 4 post LAIV. Biopsy samples 
were fixed in 4% paraformaldehyde and embedded in paraffin. Five μm thick sections 
were placed on Superfrost/plus slides (Fisher Scientific, Pittsburgh, PA). Slides were 
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washed with TBS and blocked with Powerblock (Biogenex, San Ramon, CA) for 1 hr at 
room temperature. Following this, cells were incubated with mouse anti-human pan γδ 
TCR (ThermoScientific) overnight at 4°C. After incubation with primary antibody, cells 
were washed with TBS followed by incubation with HRP-conjugated secondary 
antibodies (Vector Labs, Burlingame, CA) for 1 hour at room temperature. Cells were 
washed with TBS and evaluated under light microscopy.  
Nasal Biopsy PCR 
Nasal biopsies were obtained on screen day and day 4 post LAIV. RNA from 
nasal biopsies was isolated as described before. Total RNA was extracted using TRizol 
(Invitrogen) as per the supplier’s instruction. First-strand cDNA synthesis and real-time 
RT-PCR was performed as described previously (15, 16). The mRNA analyses for CD3γ, 
Vγ3 TCR, and Vδ1 TCR were performed using commercially available primer and probe 
sets (inventoried Taqman Gene Expression Assays) purchased from Applied Biosystems 
(Foster City, CA). NEC obtained from nasal biopsies and differentiated ex vivo as 
described before (188) were used as negative controls for T cell mRNA. PBMC were 
used as a positive control for T cell mRNA. 
Statistical Analysis 
The effects of smoking status on nasal biopsy responses to LAIV were analyzed 
using a Kruskal-Wallis one-way ANOVA followed by a Dunn’s post hoc test. Data were 
shown as mean ± SEM or median (interquartile range). 
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Results 
T cells Are Present In Nasal Biopsies At Baseline 
Nasal biopsies were harvested at screen day and processed for flow cytometry. 
The majority of nasal biopsy cells were nasal epithelial cells, characterized by their larger 
size, high side scatter fluorescence, and non-specific (negative) staining for all immune 
markers. A distinct population of immune cells was identified based on CD45 staining 
and side scatter fluorescence as shown in Figure 21A. Using a panel of surface marker 
antibodies, these cells were negative for CD16 (neutrophils), CD56 (NK cells), CD1a 
(DCs), and HLA-DR (DCs, macrophages) (Figures 21B-E). These leukocytes were 
positive for T cell marker CD3 (Figure 21F). A representative image is shown. 
LAIV Inoculation Modifies T Cell Populations in Nasal Biopsies 
Nasal biopsies were harvested at screen day, day 1, and day 4 post LAIV and 
processed for flow cytometry. CD3+CD45+ T cells were quantified as percentages of 
total nasal epithelial cells in Figure 22. By day 4 post LAIV percentages of T cells 
increased from 0.1%(0.1-1.5) to 1.1%(0.9-4.7) in nonsmokers and 0.4%(0.2-0.9) to 
1.2%(0.6-2.0) in smokers although only in nonsmokers was this increase statistically 
significant compared to baseline. Of the T cells that increase by day 4 post LAIV in 
Figure 23A, there were no CD4 T cells in nonsmoker [0.0%(0.0-0.1) or smoker 
[0.0%(0.0-0.0)] nasal biopsies and there were no statistical changes in CD4 T cell 
populations throughout the study. In addition, nominal percentages of CD8 T cells were 
identified in either nonsmoker or smoker groups in Figure 23B.  
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Overall, LAIV inoculation altered the percentages of CD4-CD8-γδ TCR (+) T 
cells in nasal biopsies (Figure 24), although these increases post LAIV compared to 
screen day did not quite reach statistical significance. We determined that these T cells 
are not conventional αβ T cells but were instead γδ T cells that were positive for the γδ 
TCR (Figure 24B). We also identified γδ TCR positive cells in nasal biopsies following 
LAIV using immunohistochemistry (Figure 25). 
CD3 and γδ TCR Chains Are Identified In Nasal Biopsies By qRT-PCR 
To identify the presence of γδ T cells we quantified mRNA expression within 
nasal biopsies before and after LAIV in both nonsmokers and smokers. Through 
determining positive expression of CD3γ we identified T cells (Figure 26) and γδ T cells 
by positive expression of the TCR variable γ3 (Vγ3) chain (Figure 27A) and the TCR 
variable δ1 (Vδ1) chain (Figure 27B). LAIV did not induce transcriptional upregulation 
of TCR chain mRNA in either nonsmokers or smokers.  
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Discussion 
The modulation of γδ T cell populations in the nasal mucosa due to LAIV is a 
novel finding and is the first evidence that γδ T cells participate in LAIV-induced 
responses in humans. Like DCs and NK cells in the respiratory epithelium, γδ T cells can 
act as bridges between innate and adaptive immunity by regulating both arms of the 
immune system. Their location in nasal mucosal epithelia allow them to quickly respond 
to virus infections, and γδ T cells sense “danger” from nearby epithelial cells through 
recognition of stressed cell ligands that are upregulated by viral infections (31) and from 
activation by virus-induced proinflammatory cytokines in the epithelia microenvironment 
(30). γδ T cells migrate to the lung during influenza infections (38; 39) which correlates 
with the similar response we see in nasal mucosa. γδ T cells respond to viral infections 
both by killing virus infected epithelial cells similar to cytotoxic T and NK cells (30) and 
also by producing cytokines such as IFNγ, IL-17, and MCP-1 that induce immune cell 
chemotaxis (30). Therefore, γδ T cells and NK cells have some functional redundancy, 
and both cell types could contribute to LAIV induced levels of granzyme B (Chapter 3) 
as well as IFNγ (3) in the NLF, although it is likely that NK cells contribute more than γδ 
T cells to these NLF responses based on their location. We did not observe significant 
migration of CD4 or CD8 T cells to the nasal mucosa by day 4 post LAIV. This is likely 
because influenza specific lymphocytes like CD8 T cells do not migrate to the airways 
until day 7 post infection (189). Modifying our LAIV protocol to include later time points 
could capture influx of influenza specific CD4 or CD8 T cells. Therefore, γδ T cells play 
a significant role in nasal mucosal T cell activity during the early adaptive immune 
responses to LAIV.    
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γδ T cell migration to the nasal mucosa after LAIV is similar between 
nonsmokers and smokers. Because we did not observe a noticeable smoking effect, we 
speculate that intraepithelial lymphocyte activation in the nasal mucosa does not 
contribute to increased risk of influenza infections documented in smokers. In fact, 
differences in innate immune responses that we (3; 53; 174) and others have documented 
in the case of cigarette smokers may contribute to the underlying mechanisms of virus 
susceptibility rather than adaptive immune responses. In our studies we did not observe 
differences in T cell specific immunity to LAIV between nonsmokers and smokers. This 
is similar to other data that demonstrate humoral influenza vaccine memory is the same in 
nonsmokers and smokers (71-73). Thus, while innate immune defense responses are 
impaired in smokers, nasal mucosal adaptive immune responsesmay not be affected by 
smoking status. 
Although we found detectable T cell specific receptor chain mRNA (CD3ε, Vγ3, 
Vδ1) in nasal biopsies, we did not observe LAIV-induced changes in receptor chain 
mRNA in either group despite finding increased percentages of T cells by day 4 post 
LAIV by flow cytometry. However, T cell activation may not always correspond with 
upregulation of T cell receptor chain transcription. In fact, activation of the TCR/CD3 
complex by phorbol myristate acetate (PMA) and anti-CD3 in T cells leads to increased 
cytokine production and increased T cell proliferation, but actually inhibits the 
transcription of CD4, CD8, and TCR α,β, and γ mRNA as well as increases mRNA 
degradation (190; 191).While mRNA expression of T cell receptor chains may be used to 
classify γδ T cell subtypes (185; 186), mRNA expression may not necessarily correlate 
with T cell activation states. In addition, although both Vγ3 and Vδ1 TCR chains have 
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been identified in the nasal mucosa (185; 186), these chains may not be predominant in 
this particular γδ T cell population. A thorough analysis of variable TCR chains in LAIV 
infected nasal γδ T cells is necessary to characterize this population.   
The ability to identify and characterize a relatively rare cell population (less than 
5% of total nasal mucosa cells are γδ T cells) from human biopsy samples by flow 
cytometry could be a useful technique to examine immunotoxicological responses of 
other rare mucosal cell types. For example, γδ T cells are located at high concentrations 
in other mucosal tissues including the gut (192). These in vivo T cell assays could provide 
an approach to determine the effect of environmental factors on immune responses in 
mucosal tissues throughout the body and could prove useful to toxicologists and vaccine 
developers. 
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Table 4. Subject Characteristics and Tobacco Smoke Exposure: Year 2 
 Nonsmoker Smoker 
 (N = 13) (N = 12) 
Age (yr) 21.5 ± 0.7 25.3 ± 1.3 
Gender 8M/5F 10M/2F 
BMI 25.0 ± 1.6 24.8 ± 1.7 
Daily exposure  
Smoked
1
 NA 11.2± 1.6 
 
1
 Data shown as mean ± SEM for cigarettes smoked. Data were averaged from each 
subject's self reported estimates for study days 0 through 9.  
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Figure 21. T Cells Are Present in Nasal Biopsies 
Nasal biopsies obtained on screen day were processed and stained with immune markers 
for flow cytometric analysis. A) Nasal leukocytes were identified based on SSC voltages 
and positive staining for CD45. Expression of immune markers for B) neutrophils, CD16, 
C) NK cells, CD56, D) DCs, CD1a, E) DCs and macrophages, HLA-DR, and F) T cells, 
CD3. A representative image is shown.  
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Figure 22. T Cells Increase in Nasal Biopsies Following LAIV. 
Nasal biopsies obtained pre LAIV and day 1 and day 4 post LAIV were processed and 
stained with immune markers for flow cytometric analysis. CD45+CD3+ T cells were  
quantified in the nasal biopsies as percentages of total cells. Kruskal-Wallis p<0.05, * 
p<0.05 vs pre LAIV.  Nonsmoker n=13, smoker n=12. 
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Figure 23. CD4 and CD8 T Cell Percentages Are Minimal Following LAIV. 
Nasal biopsies obtained pre LAIV and day 1 and day 4 post LAIV were processed and 
stained with immune markers for flow cytometric analysis. A) CD45+CD3+CD4+ 
(Kruskal-Wallis p=0.0625) and B) CD45+CD3+CD8+ T cells were quantified in the 
nasal biopsies as percentages of total cells. Nonsmoker n=6, smoker n=5.
102 
 
Figure 4
A
B
Pre LAIV D1 Post LAIV D4 Post LAIV Pre LAIV D1 Post LAIV D4 Post LAIV
0
1
2
3
4
5
6
7
Nonsmoker Smoker
P
e
rc
e
n
t 
C
D
3
+
C
D
4
-C
D
8
-
T
 C
e
ll
s
 (
%
)
Pre LAIV D1 Post LAIV D4 Post LAIV Pre LAIV D1 Post LAIV D4 Post LAIV
0
1
2
3
4
5
6
7
Nonsmoker SmokerP
e
rc
e
n
t 
C
D
3
+
γ
δ
+
C
D
4
-C
D
8
-T
 C
e
ll
s
 (
%
)
 
Figure 24. LAIV Modulates γδ T Cell Percentages in Nasal Biopsies in Nonsmokers and 
Smokers. 
Nasal biopsies obtained pre LAIV and day 1 and day 4 post LAIV were processed and 
stained with immune markers for flow cytometric analysis. A) CD45+CD3+CD4-CD8- 
and B) CD45+CD3+CD4-CD8-γδ T cells were quantified in the nasal biopsies as 
percentages of total cells. Nonsmoker n=6, smoker n=5. Kruskal-Wallis p<0.05
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Figure 25. γδ T Cells Are Present In Nasal Biopsies: Immunohistochemistry. 
Nasal biopsies were harvested before (A) and after (B) LAIV inoculation. Biopsies were 
fixed and embedded in paraffin. Biopsies were stained for immunohistochemistry with 
anti-γδ-TCR-HRP (black arrows) to identify γδ T cells. A representative image is shown. 
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Figure 26. CD3γ mRNA is Present in Nasal Biopsies. 
Nasal biopsies obtained pre LAIV and day 4 post LAIV were processed for mRNA 
analysis. Expression of CD3γ mRNA was quantified in nasal biopsies and did not change 
with LAIV or smoking status. Differentiated NEC and PBMC were used as negative and 
positive controls for T cell mRNA, respectively. Data are normalized to βactin mRNA 
levels. Nonsmoker n=10, smoker n=12. 
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Figure 27. γδ TCR mRNA is Present in Nasal Biopsies. 
Nasal biopsies obtained pre LAIV and day 4 post LAIV were processed for mRNA 
analysis. Expression of A) Vγ3 and B) Vδ1 mRNA was quantified in nasal biopsies and 
did not change with LAIV or smoking status. Differentiated NEC and PBMC were used 
as negative and positive controls for T cell mRNA, respectively.  Data are normalized to 
βactin mRNA levels. Nonsmoker n=10, smoker n=10.
  
 
 
CHAPTER 5 
GENERAL DISCUSSION 
“Not smoking is the single most important thing you can do to prolong life.” 
(193) This quote is from the book Know Your Chances: Understanding Health Statistics, 
which portrays the risk of dying from various causes such as vascular disease, cancer, and 
pneumonia based on age, gender and smoking status (193). CS exposure is associated 
with multiple illnesses including lung cancer, emphysema, COPD, cardiovascular 
disease, and stroke. CS exposure is associated with an increased risk of viral infections, 
such as influenza (43-45) and by using ex vivo and in vivo models of influenza infection, 
we suggest that smokers have suppressed antiviral responses of NEC, DCs, and NK cells. 
This mechanism of antiviral suppression could be extended to other pollutants such as 
DE or SHS that have relevant affects of respiratory health. 
Advantages and Disadvantages of Human Exposure Models 
Conducting clinical research is both rewarding and challenging. In these studies, I 
was fortunate to use both in vivo and ex vivo models of human influenza infection to 
determine differences in viral susceptibility between normal and pollutant-exposed 
populations. By using an FDA-approved vaccine, our study had the added benefit of 
protecting our subjects from influenza infections. Using all human-based models 
increased the significance and relevance of my findings. However, there are challenges in 
conducting research using human subjects. In clinical research, the human subject is the 
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top priority. Unlike when performing animal or strictly in vitro studies, researchers must 
rely on the relationships they develop with their subjects to encourage study participation 
and limit factors such as subject dropout and study noncompliance. The inability to 
control certain confounding factors (i.e. air pollutant exposures or respiratory infections 
that are exogenous to the study) necessitates complex data analyses highlight potentially 
important but subtle findings in our subject populations.  
Other challenges of working within human exposure models are the technical 
limitations. In rodent models of influenza infection, one can extract the entire lung from 
the animal and measure immune responses at the cellular, tissue, and organ level. One 
can perform mechanistic studies by either over or under-expressing molecules important 
in the immune response. We are limited in these respects when using human models. The 
challenge in garnering mechanistic data from human studies could be addressed twofold: 
1) develop complex assays using sensitive and specific techniques like flow cyometry to 
assess immune response in tissues acquired using noninvasive methods and 2) use 
human-derived cells to “build” organotypic culture conditions that both mimic in vivo 
tissues and can be manipulated to test hypotheses. To expand upon the co-culture model 
presented in this project, our laboratory is currently developing a triple cell co-culture 
model of the nasal mucosa to examine interactions between NK cells, NEC, and DCs 
using cells from either normal populations or diseased populations such as atopic 
asthmatics. I believe the work described in this dissertation will provide a foundation to 
increase the usefulness and sophistication of in vitro cell culture models while preserving 
in vivo relevance. Hopefully, elegant and innovative assays will supply researchers with 
tools to manage the technical limitations that accompany human research.  
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How Does Cigarette Smoke Modify Antiviral Defenses? 
Our lab has shown that smokers (3) and NEC obtained from smokers (53) have 
increased markers of influenza viral infection with decreased activation of antiviral 
defenses in the epithelium. I have demonstrated that in these influenza infection models, 
specific activities of cytotoxic NK cells, DCs, and NEC are suppressed in smokers. 
However, γδT cell function in the nasal mucosa remains similar between nonsmokers and 
smokers, perhaps because γδT cells in the submucosa are not directly exposed to CS in 
the airways. Therefore, suppression of some innate but perhaps not adaptive immune 
cells in smokers during viral infections may be contributing to smokers’ enhanced viral 
susceptibility.  
Smokers Have Suppressed Type I IFN Responses to Influenza Virus 
The exact mechanism that causes innate immune suppression in smokers is still 
unknown. Because NK cells, DCs, and NEC communicate along multiple axes including 
through “hardwired” receptor interactions and also “wireless” cytokine or exovesicle 
secretion, it is difficult to determine if, for example, suppressed NEC activity causes 
suppressed NK cell activity, or vice versa, or both. One common pathway that is 
suppressed in both NEC and DCs in our in vitro smoker co-culture model is the type I 
IFN pathway (53; 194). In this case, it is clear that the lack of IFNα secreted by NEC 
from smokers is likely responsible for depressed DC activation following an influenza 
infection. Suppressed type I IFN could also suppress NK cell activity in the local mucosa. 
As our lab has previously shown, the methylation of IRF7 genes in smokers (53) could be 
a mechanism for this IFN-dependent suppression. We have also demonstrated that nasal 
biopsies from smokers have increased DNA (cytosine-5)-methyltransferase 1 (DNMT1), 
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an enzyme that maintains DNA methylation patterns during DNA replication (53). 
Therefore, once exposed to DNA methylating agents, NEC in chronic smokers may be 
more likely to perpetuate these epigenetic changes. This hypothesis could be addressed 
by treating healthy NEC from nonsmokers with DNA methylating agents ex vivo to 
create a “smoker” phenotype followed by influenza virus challenge. Silencing of the type 
I IFN pathway through epigenetic modification could be responsible for the suppressed 
antiviral to influenza responses seen in smokers.  
Epigenetic Gene Modification in Smokers 
Carcinogenic compounds in CS are likely responsible for gene methylation in 
smokers. Because smoking increases the risk of lung cancer (193), most of what we know 
about epigenetic effects of smoking in the lung is from tracking aberrant gene 
methylation patterns found in lung tumors. Methylation of CpG islands in promoters 
silences genes and enables tumor cell proliferation (195). Many genes important in tumor 
progression like p16, retinoic acid receptor β (RAR-β), RASSF1A, death-associated 
protein kinase (DAPK), and O6-methylguanine-DNA methyltransferase (MGMT) are 
methylated in non small-cell lung cancer (NSCLC) (195). There are many carcinogenic 
agents in CS including N-nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone 
and N’-nitrosonornicotine, PAHs, aromatic amines, formaldehyde, volatile hydrocarbons, 
organic compounds, and heavy metals (196) that could contribute to these methylation 
changes. For instance, benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE) methylated the 
RAR-β2 promoter in both murine lung cancer and esophageal epithelial and cancer cells 
(196). The functional consequences of methylation of the RAR-β2 promoter included 
enhanced expression of epidermal growth factor receptor (EGFR), ERK1/2, activator 
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protein 1 (AP-1), and cyclooxygenase-2 (COX-2) (196). Nicotine in CS methylated the 
promoter of the tumor suppressor gene fragile histidine triad (FHIT) in esophageal 
squamous cell carcinoma cell lines (196). Nicotine also enhanced the expression of DNA 
methyltransferase 3a (DNMT3a), an enzyme that is responsible for directly methylating 
promoter sites (196). Carcinogenic agents in CS also induced methylation of genes such 
as HtrA serine peptidase 3 (HtrA3) (197) and runt-related transcription factor 3 (RUNX3) 
(198). CS exposure can also induce gene methylation indirectly by exposing individuals 
to radiation. Tobacco is grown in soil containing polonium-210 (
210
Po), a source of 
ionizing α-radiation (199). Consequently, radioactive (210Po) as well as radioactive lead-
210 (
210
Pb) are components of CS (199). In fact, two-pack-a-day smokers have 
approximately seven times the background level of radiation of inhaled 
210
Po in the 
bronchial epithelium (199). This increase in α-radiation is associated with increased lung 
tumor incidence and methylation of the tumor suppressor gene p16 (199). Therefore, 
DNA methylating agents in CS are likely responsible for modifying many genes 
important in lung tumor progression as well as antiviral defense such as IRF7. A genome-
wide analysis of DNA methylation patterns in NEC from smokers and non-smokers has 
identified additional genes potentially involved in antiviral defense responses that are 
differentially methylated in these two populations. Ongoing and future studies conducted 
in our lab will further examine their role in the suppressed antiviral defense responses 
seen in the nasal mucosa from smokers.  
Reversibility of Epigenetic Modification in Smokers 
Are these methylation changes reversible following smoking cessation programs? 
Studies have shown that in former smokers, smoking induced changes in gene 
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methylation patterns persist. For example, in patients with squamous cell lung carcinoma, 
both current and ex smokers were more likely to have positive methylation of both the 
p16 and FHIT genes compared to never smokers with carcinoma (200). Smoking can also 
cause reductions in gene methylation through modification of demethylating enzymes 
and therefore increase gene expression (201). For example, the promoter of monoamine-
oxidase, a catabolic enzyme important in serotonin release, was hypomethylated in both 
smokers and former smokers compared to never smokers (201). The question of the 
reversibility of CS induced gene expression changes was addressed by analyzing 
bronchoscopy tissue from never smokers, former smokers, and current smokers for 
differential gene expression using microarray mRNA analysis (202). Linear model 
analysis identified 175 genes that were distinctly expressed between the 3 groups and 
were classified as rapidly reversible, slowly reversible, or irreversible (202). Genes that 
were slowly reversible or irreversible include those encoding metallothioneins, proteins 
that bind heavy metals, and the T cell chemokine CX3CL1 or fractalkine (202). Rapidly 
reversible genes included those involved in carcinogenic compound metabolism, 
especially those that regulate oxidoreductase activity (202). However, for genes such as 
IRF7 that are important in antiviral defense, it is unknown if methylation is reversible. 
Our laboratory is currently collecting nasal biopsies from smokers before and after the 
start of a smoking cessation program to determine if methylation of IRF7 in smokers is 
transient or permanent. Understanding if former smokers compared to current smokers 
have similar methylation changes in genes that regulate antiviral responses would 
highlight the effects of smoking cessation on respiratory antiviral immunity.  
Can We Rescue Antiviral Defense in Smokers Using Antioxidants? 
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Understanding the mechanism by which CS leads to decreased influenza induced 
immune responses could allow us to devise smoker-specific therapeutics. This would 
decrease both the adverse health effects suffered by smokers in North Carolina and the 
economic costs to our state that occur during a pandemic outbreak. Because CS is an 
oxidant air pollutant, one “therapeutic” that might improve antiviral responses in smokers 
is nutritional supplementation with antioxidants. CS contains ROS like superoxide anion, 
nitric oxides, organic hydroxyl radicals, and hydrogen peroxides (203). Through 
reactions with endogenous iron, these ROS can produce endogenous hydroxyl radicals 
within tissues (203). By increasing ROS in lung epithelial cells, CS alters the redox 
balance and depletes endogenous cellular antioxidants like reduced (GSH) and oxidized 
(GSSG) glutathione (203). These antioxidant molecules neutralize ROS to prevent further 
oxidation. Pretreatment of cells with GSH prior to CS reduced H2O2 production and 
EGFR phosphorylation (204). Therefore, antioxidant supplementation has the potential to 
reduce CS induced oxidative stress. 
Antioxidant Supplementation in Influenza Infection 
Influenza infection induced oxidative stress responses in vivo (205; 206). Several 
studies suggested that supplementation with antioxidants like GSH (207) or quercetin, a 
flavonol found in fruits and vegetables, (208) was beneficial for influenza infection 
through neutralization of ROS and even suppression of viral replication. Resveratrol, a 
polyphenol antioxidant present in grapes, berries and peanuts has anti-inflammatory 
effects and inhibited influenza replication by preventing expression of viral proteins and 
increased survival in BALB/c mice (209). Polyphenolic catechins like epigallocatechin 
gallate (EGCG) found in green tea inhibited influenza infection in MDCK cells by 
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suppressing hemagglutination, neuraminidase activity, and viral RNA synthesis (210). 
Selenium deficiency in differentiated human bronchial epithelial cells altered antiviral 
responses by enhancing IL-6 production, decreasing IP-10 secretion, and increasing 
influenza-induced apoptosis (188). Prophylactic use of selenium, vitamin E, glutathione, 
resveratrol, and quercetin was suggested as a regimen to protect against H5N1 avian 
influenza (211) although this has not been evaluated in humans. However, vitamin A, C, 
and E supplementation had no effect on risk of community-acquired pneumonia in 
women (212). Therefore, antioxidant supplementation may be beneficial in experimental 
influenza infections, but these findings have not yet been replicated in humans.  
Antioxidant Supplementation in Smokers 
Will supplementation with antioxidants in smokers reduce oxidative stress or 
inhibit influenza-specific virology? Smokers had decreased plasma levels of vitamin C, 
E, and beta-carotene although these deficiencies were not always seen in the airways 
(209). Alveolar macrophages from smokers and people with COPD treated with 
resveratrol had suppressed IL-8 and GM-CSF release via suppression of NF-kb, AP-1, 
Cox1, and Cox2 activation (209). However, it is unclear if supplementation with 
antioxidants will ameliorate CS induced suppression of antiviral defenses. Nrf2 is a 
transcription factor that regulates expression of antioxidant molecules and is protective 
against both CS and RSV induced airway damage (213). Nutritional supplements such as 
EGCG and sulforaphane are potent inducers of Nrf2 (214). Our laboratory is currently 
conducting a study that supplements nonsmokers and smokers with sulforaphane and 
measures in vivo responses to influenza. Antioxidant supplementation may be a 
convenient way to inhibit the effects of CS exposure on influenza infection.  
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Role of Cigarette Smoke Exposure and Respiratory Viruses in Other Airway Diseases 
Asthma 
Cigarette Smoke Exposure Increases Risk and Severity of Asthma 
McLeish et al provide a systematical review examining the association between 
CS exposure and asthma (215). Although individual studies were conflicting, overall the 
authors determined that smokers were more likely to have asthma than nonsmokers and 
that smoking increased the risk for developing asthma (215). This association was overall 
more common in female smokers vs male smokers (215). Smoking also increased the risk 
of asthma exacerbations, the severity of asthma symptoms, and decline in lung function 
(215). Smoking decreased responses to inhaled corticosteroids, indicating that smokers 
may have more difficulty controlling their asthma (215). However, the authors 
determined that risk of asthma was not enough to deter smoking habits (215). Although 
smoking is a personal choice, it is alarming that SHS also contributes to asthma 
pathogenesis especially in young children. A recent review examines the role of indoor 
air pollution on asthma incidence in children because Americans spend the majority 
(90%) of their time indoors (216). SHS, a significant contributor to indoor air pollution, 
increased the risk, severity, and mortality of asthma in children (216). This susceptibility 
begins early. In utero SHS exposure from the mother decreased lung function, increased 
asthma symptoms, and even enhanced the likelihood that a child will develop 
corticosteroid resistance (216). Overall, CS exposure both increases the risk for and 
enhances the severity of asthma, especially in children.  
Role of Respiratory Viruses in Asthma 
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In a recent review, Busse et al discuss current knowledge of the role of respiratory 
viruses in both asthma onset and asthma exacerbations (217). The “hygiene hypothesis”, 
based on epidemiological studies of children who are in daycare or who have older 
siblings, suggests that frequent viral infections early in life can be protective against 
developing allergic disease or asthma (217). However, not all respiratory infections in 
early life appear beneficial for allergic airway diseases. In fact, one cohort study 
demonstrated that among children who wheeze in the first 3 years of life, detection of 
RSV and HRV by PCR in nasal wash cells increased the risk of asthma development by 
age 6, especially when combined with allergic sensitization (217). However, to explain 
this phenomenon, some have suggested there are common genetic predispositions to both 
respiratory viruses and asthma development. PCR analysis of samples from children 
undergoing asthma exacerbations revealed that respiratory viruses were associated with 
an overwhelming 85% of all asthma exacerbations with HRV responsible for two-thirds 
of all virus induced exacerbations. Thus, like CS exposure, respiratory viruses are 
involved in both the pathogenesis and exacerbation of asthma and allergic airway 
diseases. Potential mechanisms for this relationship include the ability of both viruses and 
allergens to induce immune responses that damage the airway epithelium and thereby 
increase the potential of either viruses or allergens to create secondary airway 
inflammation (217). Also, either virus or allergen induced perturbations of the Th1/Th2 
cytokine axis may play a role in this association. Upon exposures to pathogens, DCs 
traditionally direct a Th1 mediated T cell response that may be protective against a Th2 
mediated allergic T cell response in a mechanism that is supportive of the “hygiene 
hypothesis”. However, it has been demonstrated that both allergens and certain viruses 
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like HRV can induce the secretion of TSLP, a Th2 cytokine that drives allergic reactions 
(218). Therefore, a possible mechanism for the role of virus infections in asthma 
pathogenesis is that early infection with HRV could “train” the airway epithelium to 
respond in a Th2 manner and promote development of allergic sensitization and reactions 
later in life (217). Taken together, current data show that although the role of respiratory 
viruses in asthma onset is unclear, respiratory viruses play a significant part in asthma 
exacerbations. Therefore CS exposure can have a two-pronged deleterious effect on 
children by first increasing the risk of developing asthma and second by increasing the 
likelihood one will suffer virus-related asthma complications. Controlling both CS 
exposure and the spread or respiratory viruses could dramatically improve the health of 
asthmatic children.  
Chronic Obstructive Pulmonary Disease 
Cigarette Smoke and Air Pollutant Exposure Increases Risk of COPD 
COPD is defined as chronic lung disease that may include emphysema and 
chronic bronchitis with symptoms such as irreversible airway obstruction and loss of lung 
function (219). Extensive research shows that personal smoking increases the risk of 
COPD, and in 1984 the surgeon general determined that smoking causes 80-90% of 
COPD cases in the United States (220). However, not all smokers develop COPD, and 
smoking does not account for all cases of COPD worldwide (220). Besides smoking, 
other factors are attributed to COPD incidence. In public statement by the American 
Thoracic Society, researchers determined that genetic susceptibility (like α1-antitrypsin 
deficiency) and occupational exposures in coal miners, rock miners, tunnel workers, and 
concrete workers were linked to COPD causation (220). Exposure to other exogenous 
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factors like SHS, biomass, and outdoor air pollution like automobile exhaust were also 
associated with COPD (220). Once COPD is established, CS exposure contributes to 
disease progression by creating “frustrated” lung phagocytic cells such as macrophages 
and neutrophils that cannot remove foreign particulates or antigens and therefore secrete 
excess metalloproteases, proinflammtory cytokines, and ROS that cause tissue damage 
(221). Therefore, both CS and other air pollutants can contribute to COPD pathogenesis 
and may share similar mechanisms.  
Role of Respiratory Viruses in COPD 
Respiratory viruses contribute to COPD disease. In particular, respiratory viruses 
like influenza, HRV, and RSV have been identified in COPD patients using PCR 
technology (222). Seemungal et al identified specific respiratory viruses in individuals 
with COPD both during exacerbations and during disease stability (223). They found that 
40% of COPD exacerbations were associated with virus infections, and COPD patients 
with virus induced exacerbations had longer recovery times (223) Of those virus induced 
exacerbations, 58% were positive for HRV, 29% were positive for RSV, 16% were 
positive for influenza A or B, and 11% were positive for coronavirus (223). Another 
similar cohort study showed that respiratory viruses were identified in 56% of COPD 
patients with rhinovirus contributing the most at 36% of all virus induced exacerbations 
(224). Some COPD cases were positive for multiple respiratory viruses (223; 224). The 
role of influenza infection in COPD exacerbations appears to depend on vaccination 
status (222). In a cohort of patients with chronic lung disease, patients without influenza 
vaccinations were twice as likely to be hospitalized and were more likely to die from 
COPD (222). This mechanism of virus induced exacerbation in COPD could be due to 
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dysregulation of respiratory immune responses. Data shown in this dissertation 
demonstrated that overall, current smokers without COPD had suppressed nasal innate 
immune type I IFN antiviral defenses. However, in COPD patients, CS exposure may 
enhance inflammatory responses such as IL-6 and IL-8 to respiratory viruses (222). This 
enhanced inflammatory response has also been shown in mice, as chronic CS exposure 
increased type I IFN, IL-18, IL-12, and IFNγ responses to poly I:C (225). Respiratory 
viruses may also play a role in COPD pathogenesis itself. RSV was detected in 32.8% of 
sputum samples from COPD patients at baseline, and RSV infection correlated with 
increased inflammation and decreased forced expiratory volume in 1 minute (FEV1), a 
common indicator of lung function (226). Therefore, chronic respiratory virus infection 
may contribute to COPD progression and disease worsening beyond acute exacerbations. 
Although it is unclear if COPD status itself increases the risk of respiratory virus 
infections compared to normal individuals (222), respiratory viruses clearly play 
important roles in both COPD pathogenesis and exacerbations.   
Public Health and Economic Implications of Cigarette Smoke and Indoor Air Pollution  
Smoking is a Local and Global Problem 
Despite its health consequences, smoking remains a serious problem worldwide 
and in the US. In some Asian countries, smokers exceed 60% of males over 15, and 
countries such as Mongolia, Romania, Yugoslavia, Yemen and Kenya have combined 
male and female smoking rates of 44% or higher (227). Although smoking rates are 
comparatively lower in the US, approximately one fifth of US adults smoke (228). The 
2004 Surgeon General’s Report details that 400,000 Americans will die each year from 
cigarette smoking with a decreased life expectancy of 12-13 years (228). Overall, the 
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CDC estimated between 2000 and 2004 in the US, smoking was responsible for 
approximately $96 billion in direct medical costs and $97 billion in lost work 
productivity (229). These combined economic costs were calculated at $10.47 per pack of 
cigarettes (229). Due to a longstanding history of tobacco farming, North Carolina has an 
adult smoking rate of 22.6% compared to the national average of 20.5% (data from 2005) 
(228). Even more striking are data suggesting North Carolina has high percentages of 
adult, youth, and pregnant smokers, which represents a huge public health burden. In 
addition to being the US leader in tobacco production, North Carolina has high numbers 
of military bases with elevated smoking rates at approximately 32.2% (data from 2005) 
(230) in part due to donations, sales, and promotions introduced by cigarette 
manufacturers that are directed at our armed services (230). As a result, the Defense 
Department spends more than $209 million dollars annually in increased medical costs 
due to tobacco (230). Therefore, there are both health and economic costs associated with 
CS exposure. 
Second Hand Smoke Is a Worldwide Burden 
We have demonstrated that responses to viral infections are suppressed in 
smokers, but these observations can be expanded beyond active smokers to individuals 
exposed to SHS. Our data show that both in vivo (3) and ex vivo (unpublished 
observations), nonsmokers routinely exposed to SHS also have suppressed antiviral 
defenses. Worldwide, billions of people are exposed to SHS. An impressive retrospective 
analysis using data from 192 countries revealed that overall 40% percent of children, 
35% of female nonsmokers and 33% of male nonsmokers were exposed to SHS in 2004 
(231). Adult exposures generally occurred at home or in the workplace and child 
120 
exposures were attributed to smoking parents. SHS exposure in nonsmokers decreased 
disability-adjusted-life-years (DALYs), an estimate of disease burden that quantifies 
years of life lost to poor health, illness, and death, by 10.9 million (231), and 0.7% of 
DALYs total disease burden worldwide were due to SHS (231). In children under 5, 
increases in lower respiratory tract infections in children exposed to SHS contributed the 
most to disease burden (231). In the US, it is estimated that exposure to SHS causes over 
$10 billion in increased costs of mortality, morbidity, and medical care annually (232). 
The dual threat of North Carolina’s high smoking rates combined with both seasonal and 
pandemic influenza infection impacts our state’s health and economy. In April 2009, the 
local outbreak of the H1N1 influenza A strain (formerly known as the “swine flu”) 
emphasized that our community needs to combat influenza infection aggressively. 
Ambitious vaccination programs and public health education to address hygienic 
practices may limit the spread of respiratory viruses in the community at large and in 
populations susceptible to respiratory virus infections, particularly those exposed to CS 
and SHS. Because SHS increases respiratory disease incidence both in North Carolina 
and worldwide, reducing SHS exposure through smoking cessation programs is an 
attractive goal. 
Reducing Indoor Air Pollution 
Smoking Bans and their Health Effects 
For public health officials, this research underscores the importance of smoking 
cessation programs and smoking bans in protecting citizens not only from smoking 
associated diseases like lung cancer and emphysema but also from diseases that are 
exacerbated by smoking like influenza. Within the last decade, many countries and some 
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US states have implemented workplace smoking bans (233). North Carolina lawmakers 
recognize the threat of tobacco, and the North Carolina state senate passed a bill to ban 
smoking in bars and restaurants statewide effective January 2010 (234). On January 1
st
, 
2008, UNC followed UNC Hospitals to institute a campus wide smoking ban to protect 
its students and employees from the deleterious effects of SHS. Do these smoking bans 
have health benefits? A review assessing the effects of smoking ban legislation 
determined that workers felt fewer respiratory symptoms following the ban, and some 
studies reported increased lung function (233). Although the effects of smoking bans on 
respiratory infections specifically have not yet been determined, it is very impressive that 
implementing smoke-free laws caused a drop in percentages of myocardial infarction in 
the general population (233) thereby demonstrating the effectiveness of smoking bans.  
Reducing Biomass Exposure 
Biomass exposure from burning coal, wood, dung, and crop remains is a 
significant component of air indoor air pollution, especially in rural areas, and represents 
a global threat to respiratory health (114). Efforts suggested to reduce solid fuel exposure 
during cooking include avoidance through cooking outdoors, cooking in shifts, keeping 
children away from fires, or switching to “cleaner burning” fuel sources such as 
petroleum or natural gas (235). Technological advances could render biomass fuel 
emissions less toxic. Retrofitting old stoves to include chimneys and hoods to draw 
smoke away from users could be beneficial (235). Bio-filters, packed filters that contain 
biofilms of pollutant-digesting microorganisms such as bacteria or fungi, have been used 
to successfully remove ammonia and volatile organic compounds from the emissions 
food composting plants (236). Biomass waste is also generated in developed countries 
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through forestry management, as the burning of trees is necessary to clear excess growth 
(237). As an alternative to open burning, forestry waste was cut and transported to a 
biomass electricity generating facility in California for processing, and resulted in 
decreased PM, nitrogen oxides, non-methane volatile organics, carbon monoxide, and 
carbon dioxide equivalents compared with open burning (237). Therefore, sophisticated 
methods to process biomass could simultaneously increase energy output and decrease 
harmful emissions, although these technologies will certainly be limited in developing 
countries.  
Conclusions and Future Directions 
The data presented in this dissertation demonstrate how CS exposure suppresses 
innate immune responses of the respiratory epithelium. The effects of CS induced 
suppression of NEC, DC, and NK cell responses in influenza infection may extend to 
other respiratory infections as well. The mechanisms underlying CS induced 
susceptibility to influenza virus elucidated here could be applied to other respiratory 
conditions, such as exposure to airborne pollutants or to chronic airway inflammation. 
Future directions for this project include using novel triple cell co-culture assays to 
explore the mechanism underlying this suppression in specific immune cell types 
(NEC/DC/NK cells) and determining the effects of therapeutic antioxidants on 
respiratory virus infection in smokers.  
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